malignant neoplasm of female genital organs

C3_FEMALE_GENITAL

Genital neoplasm, female: Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints C3_VULVA C3_VAGINA C3_CERVIX_UTERI C3_CORPUS_UTERI C3_UTERUS_NAS C3_OVARY C3_FEMALE_GENITAL_NAS C3_PLACENTA	5841
6. Filter based on genotype QC (FinnGen only)	5841

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4

NAME	C3_FEMALE_GENITAL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE	C3_VULVA\|C3_VAGINA\|C3_CERVIX_UTERI\|C3_CORPUS_UTERI\|C3_UTERUS_NAS\|C3_OVARY\|C3_FEMALE_GENITAL_NAS\|C3_PLACENTA
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to malignant neoplasm of female genital organs based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5841	5841	-
Unadjusted period prevalence (%)	1.99	1.99	-
Median age at first event (years)	63.41	63.41	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5421: Matched controls
54210

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

ZXC96

NOMESCO Finland

Robot assisted procedure

40.0

323.0

619

174

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

33.8

323.0

1035

375

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

323.0

645

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

17.4

323.0

1151

825

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

5.4

323.0

1731

4318

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

11.2

323.0

1107

1209

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

+∞

323.0

431

JN4BD

NOMESCO Finland

Extensive body CT

6.1

323.0

1506

3224

A04AA01

ATC

ondansetron; systemic, rectal

8.8

323.0

1327

1929

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

411.3

323.0

942

B01AB10

ATC

tinzaparin; parenteral

12.1

323.0

1614

1830

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

588.9

323.0

2305

N95.0

ICD-10 Finland

Postmenopausal bleeding

5.0

323.0

1608

4249

B01AB05

ATC

enoxaparin; parenteral

3.7

323.0

2911

13063

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

87.3

323.0

499

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

239.9

323.0

598

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

151.8

323.0

459

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

700.3

323.0

451

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

4.3

323.0

2995

12129

JAL30

NOMESCO Finland

Omentectomy

56.9

323.0

790

162

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

445.6

323.0

838

128

Kela drug reimbursment

Cancers of female genital organs

958.9

323.0

2125

A03FA01

ATC

metoclopramide; systemic, rectal

4.3

323.0

2420

8545

C56

ICD-10 Finland

Malignant neoplasm of ovary

519.9

323.0

433

LCD00

NOMESCO Finland

Hysterectomy

7.4

323.0

1101

1807

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

928.6

323.0

1587

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

14.2

323.0

1787

1808

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

6.6

323.0

1629

3296

H02AB02

ATC

dexamethasone; systemic

7.2

323.0

1728

3324

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

195.9

323.0

466

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

6.9

322.5

878

1478

WX302

NOMESCO Finland

Thoracal epidural anesthesy

7.8

320.9

796

1169

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

9.2

319.9

713

880

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

9.9

315.4

670

759

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

43.1

312.6

392

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

9.8

305.4

655

753

WF003

NOMESCO Finland

Adjuvant radiotherapy

8.4

289.2

678

904

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

719.5

279.9

274

JEA00

NOMESCO Finland

Appendectomy

6.6

276.1

773

1336

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

6.6

276.0

772

1332

JN4AD

NOMESCO Finland

Body CT examination

5.4

268.8

896

1921

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

349.0

267.2

268

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

8.9

260.5

586

725

L03AA13

ATC

pegfilgrastim; parenteral

7.0

256.4

683

1096

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

5.1

249.5

872

1961

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

159.9

246.1

259

LCA06

NOMESCO Finland

Biopsy of endometrium

3.4

244.3

1447

5257

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

+∞

241.5

230

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

22.9

240.2

354

165

JAL00

NOMESCO Finland

Biopsy of peritoneum

44.4

233.7

291

R18

ICD-10 Finland

Ascites

13.6

227.4

408

322

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

331.9

223.6

225

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

5.5

220.1

706

1427

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

196.4

218.0

226

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

23.3

213.8

313

142

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.5

212.4

2356

12564

C54.9

ICD-10 Finland

Malignant neoplasm: Corpus uteri, unspecified

275.0

207.6

211

C54.10

ICD-10 Finland

Malignant tumor of endometrium without histology

221.6

207.0

213

TPH07

NOMESCO Finland

Cathetrisation of artery

3.9

204.6

962

2851

X77

ICPC

Malignant neopl genital female other

139.2

200.9

214

L03AA14

ATC

lipegfilgrastim; parenteral

10.1

199.8

415

440

C54.19

ICD-10 Finland

Malignant tumor of endometrium, unspecified histology

506.0

197.9

196

LEB00

NOMESCO Finland

Biopsy of vagina

9.7

195.4

415

458

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

66.7

193.1

224

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

+∞

191.8

183

Z51.5

ICD-10 Finland

Palliative care

4.9

191.5

685

1553

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

+∞

187.6

179

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

329.5

187.5

189

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

97.3

186.6

206

C53.11

ICD-10 Finland

Squamous cell carcinoma and exocervix

1929.0

183.3

177

JAL31

NOMESCO Finland

Laparoscopic omentectomy

77.0

182.1

207

XX3DW

NOMESCO Finland

Time consuming IT work

3.5

174.8

927

3002

A04AA55

ATC

palonosetron, combinations; systemic

6.7

170.1

461

743

8070/3-C53.9

ICD-O-3

Squamous cell carcinoma, NOS, of cervix uteri

854.6

169.8

166

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

13.7

169.2

301

231

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

12.2

169.0

318

276

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

16.3

158.4

262

168

C56.72

ICD-10 Finland

Mucinous epithelial carcinoma of the ovary

235.4

156.0

160

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

5.8

155.8

471

872

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

774.9

154.1

151

WW500

NOMESCO Finland

Blood transfusion

5.7

152.5

466

874

LCD30

NOMESCO Finland

Radical hysterectomy

120.8

152.0

164

1820A

ICD-9 Finland

Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]

1543.1

151.7

147

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

385.5

150.9

151

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

5.3

150.1

491

997

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

85.7

141.0

158

8441/3-C54.1

ICD-O-3

Serous carcinoma, NOS, of endometrium

1406.9

140.2

136

WX402

NOMESCO Finland

General anaesthesia

2.7

140.0

1165

5048

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

31.2

139.0

187

ULA02

NOMESCO Finland

Kolposcopy

3.1

138.9

857

3062

TLE20

NOMESCO Finland

Transvaginal puncture of cul-de-sac

47.8

136.3

167

LE090

NOMESCO Finland

Profylactive radiotherapy of vulva and vagina

1333.7

133.9

130

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.3

133.3

1546

7963

C54.12

ICD-10 Finland

Adenosquamous carcinoma of the endometrium

1321.6

132.9

129

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

199.2

131.3

136

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

7.7

129.1

313

426

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

3.0

125.9

819

3020

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

11.5

125.2

241

218

L02AB02

ATC

medroxyprogesterone; systemic (progestogens)

16.7

122.9

201

125

N85.1

ICD-10 Finland

Endometrial adenomatous hyperplasia

8.9

122.4

271

318

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

20.8

121.1

183

N02AA05

ATC

oxycodone; systemic

2.5

119.9

1133

5213

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

17.5

118.9

191

113

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

8.5

114.9

262

323

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

87.4

114.6

128

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

77.8

113.8

129

JAH01

NOMESCO Finland

Laparoscopy

4.2

112.8

458

1155

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.7

111.5

901

3783

8070/3-C51.9

ICD-O-3

Squamous cell carcinoma, NOS, of vulva, NOS

1100.6

110.9

108

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

6.9

110.2

289

440

L03AA02

ATC

filgrastim; parenteral

5.8

109.2

325

585

ZX120

NOMESCO Finland

Intravenous

2.9

109.0

746

2826

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

87.7

107.5

120

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

33.1

107.3

142

C51.01

ICD-10 Finland

Squamous cell carcinoma of the labium majus

533.3

106.1

105

WF090

NOMESCO Finland

Profylactic radiotherapy

218.2

103.9

107

C54.13

ICD-10 Finland

Clear cell carcinoma of the endometrium

1017.4

102.5

100

LFC00

NOMESCO Finland

Partial excision of vulva

41.0

101.5

128

8310/3-C56.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of ovary

+∞

101.4

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

9.2

101.1

219

247

8620/3-C56.9

ICD-O-3

Adult granulosa cell tumor of ovary of ovary

+∞

100.3

8140/3-C53.9

ICD-O-3

Adenocarcinoma, NOS, of cervix uteri

+∞

99.3

WF002

NOMESCO Finland

Radical radiotherapy

5.5

98.6

310

595

8470/3-C56.9

ICD-O-3

Mucinous cystadenocarcinoma, NOS, of ovary

+∞

98.2

C56.74

ICD-10 Finland

Mesonephroid epithelial carcinoma of the ovary

491.6

97.7

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

7.5

96.5

238

331

LCD31

NOMESCO Finland

Radical laparoscopic hysterectomy

955.2

96.3

D39.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Uterus

14.0

95.3

167

123

A04AA03

ATC

tropisetron; systemic

26.2

94.7

133

3009

Kela drug reimbursment

Niraparib

476.0

94.6

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

7.7

94.5

229

310

1830A

ICD-9 Finland

Malignant neoplasm of ovary and other uterine adnexa, Ovary

193.3

91.6

1510

Kela drug reimbursment

Niraparib

460.4

91.5

JAH00

NOMESCO Finland

Laparotomy

5.3

90.6

294

585

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.5

90.6

793

3447

8460/3-C56.9

ICD-O-3

Low grade serous carcinoma of ovary

+∞

89.8

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

109.7

89.2

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

12.3

87.5

162

135

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

31.4

87.5

117

C56.92

ICD-10 Finland

Malignant ovarian tumor, sex chord stroma derived

57.1

85.3

101

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

4.2

85.3

344

857

WF049

NOMESCO Finland

Radiotherapy of metastasis

4.9

85.0

293

623

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.8

80.7

286

626

ULC02

NOMESCO Finland

Hysteroscopy

2.9

79.5

540

2013

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

30.3

79.4

107

C54

ICD-10 Finland

Malignant neoplasm of corpus uteri

398.2

79.1

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

4.5

78.1

292

675

C51.11

ICD-10 Finland

Squamous cell carcinoma of the labium minus

393.1

78.0

A04AA02

ATC

granisetron; systemic, transdermal

2.9

76.1

505

1852

Z31.5

ICD-10 Finland

Genetic counselling

3.6

76.1

370

1084

C54.23

ICD-10 Finland

Carcinosarcoma

738.3

74.4

L01XK02

ATC

niraparib; oral

372.4

73.9

ZX070

NOMESCO Finland

Intensity modified radiotherapy

7.4

73.2

181

253

TJA10

NOMESCO Finland

Laparocentesis

32.5

72.6

C54.21

ICD-10 Finland

Leiomyosarcoma and myometrium

243.1

70.5

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

6.0

68.9

197

336

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.4

68.7

355

1089

YX9VG

NOMESCO Finland

Other MRI eamination with high intensity magnet for dose design of radiotherapy

70.8

67.3

ZXC40

NOMESCO Finland

Use of ultrasound

11.0

65.7

128

119

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

24.9

65.5

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

4.0

64.6

273

708

ZX020

NOMESCO Finland

HDR radiotherapy within tissue

101.3

64.0

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

11.0

63.7

124

115

C56.91

ICD-10 Finland

Malignant granulosa cell tumor in ovary

62.5

63.6

JN3AD

NOMESCO Finland

Abdominal CT examination

2.6

62.8

504

2065

N02BE01

ATC

paracetamol; systemic, rectal

2.0

62.2

4844

43697

LFD10

NOMESCO Finland

Vulvectomy and excision of regional lymph nodes

212.4

61.2

WF099

NOMESCO Finland

Other radiotherapy

15.8

61.1

101

C55

ICD-10 Finland

Malignant neoplasm of uterus, part unspecified

96.9

61.0

C54.0

ICD-10 Finland

Malignant neoplasm: Isthmus uteri

131.6

61.0

C51.9

ICD-10 Finland

Malignant neoplasm: Vulva, unspecified

131.6

61.0

C54.22

ICD-10 Finland

Endometrial stromal cell sarcoma

604.9

60.9

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

14.3

60.4

104

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

55.3

59.8

D07.0

ICD-10 Finland

Carcinoma in situ: Endometrium

41.6

59.2

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

3.4

58.8

303

926

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

58.5

677

3327

1XC07

NOMESCO Finland

28.0

58.3

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

5.0

58.1

193

394

N84.0

ICD-10 Finland

Polyp of corpus uteri

2.1

58.0

702

3518

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

7.1

57.2

144

207

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

17.9

57.2

WZC30

NOMESCO Finland

Teaching

2.0

56.7

780

4124

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

4.6

56.2

204

457

C53.00

ICD-10 Finland

Malignant tumor of endocervix without histology

195.4

56.1

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

2.7

56.0

419

1646

C54.2

ICD-10 Finland

Malignant neoplasm: Myometrium

+∞

55.3

C574, 8461, 3

ICD-O-3

+∞

55.3

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.3

54.5

212

509

121

Kela drug reimbursment

Severe hypofunction of sexual glands

3.9

54.1

236

629

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

46.9

53.3

8310

FHL

Radical hysterectomy (includes lymph node removal)

523.0

52.6

C53.12

ICD-10 Finland

Adenocarcinoma of the exocervix

268.4

52.2

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

10.8

52.1

102

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

12.2

52.1

8140/3-C53.0

ICD-O-3

Adenocarcinoma, NOS, of endocervix

+∞

51.1

8310/3-C54.1

ICD-O-3

Clear cell adenocarcinoma, NOS, of endometrium

+∞

51.1

8076/3-C53.9

ICD-O-3

Squamous cell carcinoma, microinvasive of cervix uteri

+∞

50.1

8480/3-C56.9

ICD-O-3

Mucinous adenocarcinoma of ovary

+∞

50.1

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

49.3

1418

9537

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

5.4

48.9

152

288

JBA10

NOMESCO Finland

Transabdominal biopsy or excision of lesion of diaphragm

107.1

48.8

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

15.2

48.5

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

5.2

48.3

155

305

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

16.5

48.2

JN4CD

NOMESCO Finland

Very extensive body CT

3.1

48.1

277

919

1511

Kela drug reimbursment

Olaparib

+∞

48.0

LC003

NOMESCO Finland

Adjuvant radiotherapy of uterus and uterine ligaments

+∞

46.9

389

Kela drug reimbursment

Olaparib

+∞

46.9

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

8.2

46.1

105

130

Z85.4

ICD-10 Finland

Personal history of malignant neoplasm of genital organs

237.0

46.0

D39.19

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary with unspecified histology

8.0

45.7

106

135

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

3.9

45.5

193

502

D39.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified

10.8

45.5

JFB00

NOMESCO Finland

Partial resection of small intestine

4.9

45.4

153

318

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

45.3

534

2628

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

8.8

44.9

113

D39.11

ICD-10 Finland

Epithelial tumor of uncertain nature in the ovary

7.9

44.8

105

136

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

6.9

44.8

114

167

18200

ICD-8 Finland

Other malignant neoplasm of uterus, Carcinoma corporis uteri

121.1

44.8

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.6

44.8

358

1457

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

6.9

44.2

113

167

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.6

44.0

158

351

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.9

43.9

126

217

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

43.7

2340

18189

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

2.7

43.4

314

1203

L02BG04

ATC

letrozole; oral

2.0

43.3

583

3033

1XA02

NOMESCO Finland

221.7

43.0

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

4.9

42.9

145

302

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

25.3

42.8

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

2.0

42.7

577

3007

ZX095

NOMESCO Finland

Combined chemoradiotherapy

10.9

42.4

C567

ICD-10 Finland

216.7

41.9

JMA10

NOMESCO Finland

Transabdominal total splenectomy

10.9

41.9

D39.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other female genital organs

17.1

41.5

C51.81

ICD-10 Finland

Squamous cell carcinoma of the vulva

60.5

41.2

8140/3-C54.1

ICD-O-3

Adenocarcinoma, NOS, of endometrium

400.5

40.1

8890/3-C54.9

ICD-O-3

Leiomyosarcoma, NOS, of corpus uteri

+∞

39.6

C53.0

ICD-10 Finland

Malignant neoplasm: Endocervix

390.3

39.1

8980/3-C54.1

ICD-O-3

Carcinosarcoma, NOS, of endometrium

+∞

38.6

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

18.1

37.9

C53.09

ICD-10 Finland

Malignant tumor of endocervix, unspecified histology

196.4

37.8

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

13.4

37.1

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

11.4

37.1

C54.29

ICD-10 Finland

Unspecified uterine sarcoma

100.8

36.7

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

35.9

692

4086

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

4.0

35.8

148

378

L01XK01

ATC

olaparib; oral

+∞

35.4

8070/3-C53.1

ICD-O-3

Squamous cell carcinoma, NOS, of exocervix

+∞

35.4

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.5

35.4

302

1271

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

6.5

34.8

143

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.5

34.5

291

1217

JFB46

NOMESCO Finland

Resection of sigmoid colon

4.4

34.4

127

291

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

34.1

667

3954

R50.9

ICD-10 Finland

Fever, unspecified

1.8

33.9

658

3892

C51.00

ICD-10 Finland

Malignant tumor of the labium majus without histology

76.6

33.8

18301

ICD-8 Finland

Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary

176.1

33.7

LCB25

NOMESCO Finland

Hysteroscopic excision of lesion

2.1

33.7

391

1907

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

6.1

33.4

155

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.3

33.4

178

559

C53.1

ICD-10 Finland

Malignant neoplasm: Exocervix

329.1

32.9

K56.7

ICD-10 Finland

Ileus, unspecified

4.3

32.8

126

301

8102

FHL

Second look"" surgery for a malignant tumor

171.0

32.7

C579, 8461, 3

ICD-O-3

+∞

32.3

C53

ICD-10 Finland

Malignant neoplasm of cervix uteri

+∞

32.3

KA1FN

NOMESCO Finland

Isotope renography

8.5

32.3

X81

ICPC

Genital neopl female other/unspecif

25.2

32.2

C52.91

ICD-10 Finland

Squamous cell carcinoma of the vagina

166.0

31.7

A79

ICPC

Malignancy NOS

4.3

31.7

120

283

JFF10

NOMESCO Finland

Loop enterostomy

8.4

31.6

C53.90

ICD-10 Finland

Malignant tumor in unspecified localization in cervix uteri without histology

+∞

31.3

C53.10

ICD-10 Finland

Malignant tumor of the exocervix without histology

+∞

31.3

L01XX54

ATC

[U] niraparib; oral

+∞

31.3

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

13.6

31.2

ZX090

NOMESCO Finland

Other technic of radiotherapy

2.8

30.9

201

724

8070/3-C52.9

ICD-O-3

Squamous cell carcinoma, NOS, of vagina, NOS

314.7

30.9

LDA10

NOMESCO Finland

Curettage of cervix uteri

2.4

30.4

262

1110

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.0

30.3

180

609

8890/3-C54.2

ICD-O-3

Leiomyosarcoma, NOS, of myometrium

+∞

30.2

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

38.3

30.2

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

11.8

29.8

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

11.1

29.4

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.6

29.3

215

833

8000/3-C56.9

ICD-O-3

Neoplasm, malignant of ovary

+∞

29.2

LWA00

NOMESCO Finland

Repair of wound dehiscence in gynaecological surgery

16.6

28.8

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

3.9

28.7

121

315

R2110

NOMESCO Finland

Giving the first information

1.9

28.1

408

2173

JN5JS

NOMESCO Finland

Extensive PET-MRI of body metabolism

64.3

27.9

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

3.3

27.9

142

432

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

27.9

333

1642

A04AD12

ATC

aprepitant; systemic

3.1

27.8

160

531

C53.99

ICD-10 Finland

Malignant tumor in unspecified localization in cervix, unspecified histology

145.7

27.6

1800A

ICD-9 Finland

Malignant neoplasm of cervix uteri, Endocervix

145.7

27.6

X75

ICPC

Malignant neoplasm cervix

145.7

27.6

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

27.5

542

3206

C48.89

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor

17.3

27.4

LCA10

NOMESCO Finland

Curettage of body of uterus

2.5

27.3

217

881

LWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gynaecological surgery

19.2

26.5

B02AA02

ATC

tranexamic acid; systemic

1.6

26.4

842

5690

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

26.3

660

4193

A06AH03

ATC

naloxegol; oral

4.8

26.2

189

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

5.9

26.2

127

D06.0

ICD-10 Finland

Carcinoma in situ: Endocervix

12.9

26.1

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

25.8

174

640

KBV10

NOMESCO Finland

Removal of stent from ureter

7.4

25.8

JFA70

NOMESCO Finland

Suture of small intestine

11.5

25.8

C54.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of corpus uteri

261.9

25.7

LAF17

NOMESCO Finland

Laparoscopic excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

135.7

25.6

HA1AA

NOMESCO Finland

X-ray mammography

1.7

25.3

607

3806

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

4.2

25.2

238

WF004

NOMESCO Finland

Palliative radiotherapy

3.6

25.2

118

337

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.3

25.1

132

412

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

11.3

25.1

8070/3-C51.1

ICD-O-3

Squamous cell carcinoma, NOS, of labium minus

+∞

25.0

8070/3-C51.0

ICD-O-3

Squamous cell carcinoma, NOS, of labium majus

+∞

25.0

L01XX46

ATC

[U] olaparib; oral

+∞

25.0

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

2.0

25.0

350

1841

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

3.1

24.8

138

449

D39.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Ovary

6.4

24.5

103

B01AB04

ATC

dalteparin; parenteral

2.0

24.4

309

1561

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

2.2

24.2

258

1212

JFA80

NOMESCO Finland

Suture of colon

14.9

24.2

R93.5

ICD-10 Finland

Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum

3.1

24.1

139

463

G03AC03

ATC

levonorgestrel; systemic

0.5

24.0

257

4598

D07.1

ICD-10 Finland

Carcinoma in situ: Vulva

20.7

23.8

LFD00

NOMESCO Finland

Vulvectomy

87.1

23.7

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

21.4

23.4

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

23.2

996

7177

N02AX02

ATC

tramadol; systemic, rectal

1.3

23.2

2097

17273

8070/3-C53.0

ICD-O-3

Squamous cell carcinoma, NOS, of endocervix

+∞

22.9

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

22.9

218

970

Z70.8

ICD-10 Finland

Other sex counselling

13.0

22.8

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

13.5

22.7

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

0.4

22.5

109

2521

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

3.9

22.5

245

ZX080

NOMESCO Finland

Image guided radiotherapy

2.7

22.3

153

569

P01AB01

ATC

metronidazole; oral, rectal

1.3

22.2

2122

17591

ZX121

NOMESCO Finland

Central venous catheter

9.1

22.0

C53.81

ICD-10 Finland

Overall squamous cell carcinoma of the cervix uteri

+∞

21.9

8980/3-C56.9

ICD-O-3

Carcinosarcoma, NOS, of ovary

+∞

21.9

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

4.7

21.8

162

C51.04

ICD-10 Finland

Basal cell carcinoma of labium majus

62.8

21.8

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

16.0

21.8

J94.8

ICD-10 Finland

Other specified pleural conditions

3.5

21.7

102

294

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

21.5

236

1122

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

9.0

21.0

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.3

20.9

196

866

K62.7

ICD-10 Finland

Radiation proctitis

60.2

20.9

8931/3-C54.1

ICD-O-3

Endometrial stromal sarcoma, low grade of endometrium

+∞

20.8

9080/3-C56.9

ICD-O-3

Teratoma, malignant, NOS, of ovary

+∞

20.8

XW2AT

NOMESCO Finland

Cytology of deep organ with ultrasound quidance

24.3

20.8

KBV00

NOMESCO Finland

Insertion of stent into ureter

6.8

20.7

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

6.1

20.7

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

20.7

355

2007

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

20.6

230

1101

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

5.6

20.4

109

G02BA03

ATC

plastic IUD with progestogen

0.5

20.1

151

3010

KA3EB

NOMESCO Finland

Antegrade pyelography

8.1

20.1

N85.0

ICD-10 Finland

Endometrial glandular hyperplasia

2.5

19.8

154

620

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

6.8

19.5

JFF23

NOMESCO Finland

Transversostomy

4.1

19.5

187

KCH00

NOMESCO Finland

Suture of bladder

8.2

19.4

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

10.1

19.3

B03XA02

ATC

darbepoetin alfa; parenteral

3.2

19.2

101

318

LEF13

NOMESCO Finland

Colpoperineoplasty and vaginal hysterectomy

0.3

18.9

1421

JJA40

NOMESCO Finland

Excision of lesion of liver

34.4

18.9

8140/3-C56.9

ICD-O-3

Adenocarcinoma, NOS, of ovary

+∞

18.8

C53.91

ICD-10 Finland

Squamous cell carcinoma in an unspecified location in the cervix

+∞

18.8

JAW96

NOMESCO Finland

Other operation on abdominal wall, peritoneum, mesentery or omentum

8.9

18.6

C53.19

ICD-10 Finland

Malignant tumor of the exocervix, unspecified histology

100.4

18.6

C51.09

ICD-10 Finland

Malignant tumor of the labium majus, unspecified histology

100.4

18.6

2180A

ICD-9 Finland

Uterine leiomyoma, Submucous leiomyoma of uterus

0.5

18.4

176

3261

5703

FHL

Removal of lymph nodes from the retroperitoneal space

25.1

18.2

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

18.0

405

2484

WX704

NOMESCO Finland

Intubation

1.8

18.0

333

1930

TLE30

NOMESCO Finland

Tamponation of vagina

9.1

17.8

Z51.0

ICD-10 Finland

Radiotherapy session

3.4

17.8

255

JFB20

NOMESCO Finland

Ileocaecal resection

6.4

17.7

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

13.7

17.7

C51.1

ICD-10 Finland

Malignant neoplasm: Labium minus

+∞

17.7

GAE03

NOMESCO Finland

Suture of chest wall

+∞

17.7

N81.1

ICD-10 Finland

Cystocele

0.6

17.5

224

3835

LAG11

NOMESCO Finland

Laparoscopic oophoropexy

180.6

17.5

8090/3-C51.9

ICD-O-3

Basal cell carcinoma, NOS, of vulva, NOS

180.6

17.5

R03AC02

ATC

salbutamol; inhalant

0.8

17.5

1991

23208

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

2.2

17.4

176

810

R07.4

ICD-10 Finland

Chest pain, unspecified

0.7

17.4

871

11346

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.1

17.3

169

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

3.2

17.2

294

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.5

17.1

136

553

C48.00

ICD-10 Finland

Malignant tumor of the retroperitoneal space without histology

17.4

16.9

Z93.3

ICD-10 Finland

Colostomy status

4.2

16.8

155

N30.4

ICD-10 Finland

Irradiation cystitis

63.5

16.7

8205

FHL

Subradical ovarian malignancy removal (includes possible genital and omet removal)

63.5

16.7

9060/3-C56.9

ICD-O-3

Dysgerminoma of ovary

+∞

16.7

8010/3-C56.9

ICD-O-3

Carcinoma, NOS, of ovary

+∞

16.7

8441/3-C57.0

ICD-O-3

Serous carcinoma, NOS, of fallopian tube

+∞

16.7

8440/3-C56.9

ICD-O-3

Cystadenocarcinoma, NOS, of ovary

+∞

16.7

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

16.5

1744

14492

JBA20

NOMESCO Finland

Transabdominal partial excision of diaphragm

170.5

16.5

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

16.4

339

2031

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.5

16.2

215

X12

ICPC

Postmenopausal bleeding

3.8

16.2

180

SPAT1109

SPAT

Analgesia with portable analgesic pump

5.3

16.1

C52.90

ICD-10 Finland

Malignant neoplasm of vagina without histologic examination

47.6

16.0

R03DC03

ATC

montelukast; oral

0.7

15.9

413

6033

N13.1

ICD-10 Finland

Hydronephrosis with ureteral stricture, not elsewhere classified

9.5

15.9

8980/3-C54.9

ICD-O-3

Carcinosarcoma, NOS, of corpus uteri

+∞

15.6

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

3.7

15.6

181

C52.99

ICD-10 Finland

Malignant tumor of the vagina, unspecified histology

85.3

15.6

JAL96

NOMESCO Finland

Other excision of lesion of peritoneum

22.1

15.5

WC402

NOMESCO Finland

Demanding antibody therapy of local recurrence of tumour

160.4

15.5

1801A

ICD-9 Finland

Malignant neoplasm of cervix uteri, Exocervix

160.4

15.5

C53.89

ICD-10 Finland

Overall malignant tumor of the cervix uteri, unspecified histology

160.4

15.5

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

5.7

15.2

C76.3

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Pelvis

28.7

15.2

SPAT1125

SPAT

Stoma care and guidance

2.6

15.2

107

410

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.3

15.1

223

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

11.8

15.0

D69.5

ICD-10 Finland

Secondary thrombocytopenia

8.1

15.0

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.7

15.0

173

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

8.5

14.9

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.6

14.9

106

408

LAF01

NOMESCO Finland

Laparoscopic unilateral salpingo-oophorectomy

2.2

14.8

150

691

XLD10

NOMESCO Finland

Gynaecological examination

6.2

14.8

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.0

14.7

280

WX400

NOMESCO Finland

Inhalation anesthesy

2.0

14.7

199

1036

L01CB01

ATC

etoposide; systemic

6.8

14.6

C53.92

ICD-10 Finland

Adenocarcinoma in an unspecified location in the cervix

+∞

14.6

C53.9

ICD-10 Finland

Malignant neoplasm: Cervix uteri, unspecified

+∞

14.6

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.5

14.5

466

3130

TJF80

NOMESCO Finland

Ostomy education

4.1

14.5

138

S18

ICPC

Laceration/cut

1.3

14.5

2055

17653

8542/3-C51.9

ICD-O-3

Paget disease, extramammary of vulva, NOS

150.4

14.5

JBA00

NOMESCO Finland

Transabdominal repair of diaphragm for rupture

36.1

14.4

WC401

NOMESCO Finland

Simple antibody therapy of local recurrence of tumour

19.2

14.2

TPX15

NOMESCO Finland

Removal of vascular injection port

5.5

14.1

K56.0

ICD-10 Finland

Paralytic ileus

4.1

14.1

133

UKC02

NOMESCO Finland

Cystoscopy

1.5

14.0

561

3957

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

6.6

14.0

21899

ICD-8 Finland

Uterine fibroma

0.6

13.9

166

2895

ZZR00

NOMESCO Finland

Flap of skin

2.3

13.9

125

546

C51.19

ICD-10 Finland

Adenocarcinoma of the labium minus, unspecified histology

53.5

13.8

N90.2

ICD-10 Finland

Severe vulvar dysplasia, not elsewhere classified

7.1

13.8

Z51.88

ICD-10 Finland

Other specified medical care

2.5

13.7

108

439

R01AD09

ATC

mometasone; nasal

0.8

13.7

1580

18567

C57.7

ICD-10 Finland

Malignant neoplasm: Other specified female genital organs

75.3

13.6

C52.92

ICD-10 Finland

Adenocarcinoma of the vagina

+∞

13.5

8720/3-C51.9

ICD-O-3

Malignant melanoma, NOS, of vulva, NOS

+∞

13.5

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

3.5

13.5

179

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

4.5

13.4

106

KC1GB

NOMESCO Finland

Cystography with X-ray

9.4

13.4

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

13.8

13.2

SPAT1153

SPAT

Removal of sutures

1.3

13.2

1598

13426

WX892

NOMESCO Finland

Monitored bed care

1.6

13.1

311

1941

A46

ICD-10 Finland

Erysipelas

1.4

13.0

608

4413

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8.3

13.0

N81.6

ICD-10 Finland

Rectocele

0.6

13.0

227

3604

C48.20

ICD-10 Finland

Malignant tumor in unspecified localization in the peritoneum without histology

22.6

12.9

C54.20

ICD-10 Finland

Malignant tumor of the myometrium without histology

50.1

12.8

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

5.3

12.8

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.7

12.8

542

7282

JFF30

NOMESCO Finland

Other colostomy

14.0

12.7

3AA13

NOMESCO Finland

7.2

12.7

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.6

12.7

213

3417

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

12.6

408

2751

8090/3-C51.0

ICD-O-3

Basal cell carcinoma, NOS, of labium majus

+∞

12.5

JN5KS

NOMESCO Finland

Very extensive PET-MRI of body metabolism

+∞

12.5

C52

ICD-10 Finland

Malignant neoplasm of vagina

+∞

12.5

C51.0

ICD-10 Finland

Malignant neoplasm: Labium majus

+∞

12.5

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

2.9

12.5

263

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

4.8

12.5

JN3DM

NOMESCO Finland

Abdominal very extensive MRI examination with 3 Tesla magnet

20.1

12.4

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.0

12.4

238

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

12.4

289

1791

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

12.3

339

2198

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

4.6

12.2

18099

ICD-8 Finland

Malignant neoplasm of cervix uteri

9.6

12.2

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

6.7

12.2

LBE10

NOMESCO Finland

Bilateral salpingectomy

21.3

12.0

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.6

11.8

336

SAA02

NOMESCO Finland

Basic examination of mouth

0.8

11.8

2361

26333

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.7

11.8

312

A98

ICPC

Health maint/preventive medicine

0.7

11.8

4712

48823

N85.9

ICD-10 Finland

Noninflammatory disorder of uterus, unspecified

3.1

11.8

210

R11

ICD-10 Finland

Nausea and vomiting

1.5

11.8

422

2907

J01DB01

ATC

cefalexin; oral

1.3

11.8

4054

38084

C10AA07

ATC

rosuvastatin; oral

0.8

11.7

779

9828

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

11.7

4457

42375

C58

ICD-10 Finland

Malignant neoplasm of placenta

65.1

11.6

C78.5

ICD-10 Finland

Secondary malignant neoplasm of large intestine and rectum

22.9

11.6

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

0.8

11.5

1141

13701

8461/3-C54.1

ICD-O-3

High grade serous carcinoma of endometrium

+∞

11.5

8140/3-C53.1

ICD-O-3

Adenocarcinoma, NOS, of exocervix

+∞

11.5

8930/3-C54.1

ICD-O-3

Endometrial stromal sarcoma, NOS, of endometrium

+∞

11.5

8380/3-C57.0

ICD-O-3

Endometrioid adenocarcinoma, NOS, of fallopian tube

+∞

11.5

8140/3-C54.9

ICD-O-3

Adenocarcinoma, NOS, of corpus uteri

+∞

11.5

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

0.6

11.5

245

3728

A02BC02

ATC

pantoprazole; systemic

1.2

11.5

3375

31106

M03BX02

ATC

tizanidine; oral

0.8

11.4

2429

26970

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

11.3

1395

16367

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

5.8

11.3

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

15.0

11.3

E89.4

ICD-10 Finland

Postprocedural ovarian failure

17.0

11.2

ZX100

NOMESCO Finland

Oral

2.8

11.2

252

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

6.8

11.1

KBH20

NOMESCO Finland

Replantation of ureter

7.1

11.0

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

0.7

11.0

510

6770

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.3

10.9

415

OAB39

NOMESCO Finland

Sexual health guidance

43.4

10.9

LAE20

NOMESCO Finland

Bilateral oophorectomy

3.7

10.9

125

JFB30

NOMESCO Finland

Right hemicolectomy

2.6

10.9

298

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.3

10.8

101

453

R06AX27

ATC

desloratadine; oral

0.8

10.7

797

9920

C51.21

ICD-10 Finland

Squamous cell carcinoma of the clitoris

28.1

10.7

C48.19

ICD-10 Finland

Malignant tumor in specified location in peritoneum other or unspecified histlogy

17.8

10.7

M01AH05

ATC

etoricoxib; oral

0.8

10.7

2332

25900

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.5

10.6

350

J45

ICD-10 Finland

Asthma

0.6

10.6

234

3537

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

10.5

360

2455

LEC00

NOMESCO Finland

Partial excision of vagina

9.2

10.5

9071/3-C56.9

ICD-O-3

Yolk sac tumor, NOS, of ovary

+∞

10.4

8323/3-C54.1

ICD-O-3

Mixed cell adenocarcinoma of endometrium

+∞

10.4

8140/3-C57.0

ICD-O-3

Adenocarcinoma, NOS, of fallopian tube

+∞

10.4

C51.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of vulva

+∞

10.4

9110/3-C56.9

ICD-O-3

Mesonephroma, malignant of ovary

+∞

10.4

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

10.4

1210

10061

R03BA01

ATC

beclometasone; inhalant

0.7

10.4

402

5489

SPAT1262

SPAT

Handing over of treatment supplies

1.3

10.3

773

6064

T80.2

ICD-10 Finland

Infections following infusion, transfusion and therapeutic injection

12.0

10.3

1DB01

NOMESCO Finland

32.6

10.3

C51.89

ICD-10 Finland

Overall malignant tumor of the vulva, unspecified histology

32.6

10.3

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

3.2

10.3

169

M25.5

ICD-10 Finland

Pain in joint

0.8

10.3

970

11738

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

0.6

10.1

118

2066

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

6.2

10.1

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

0.8

10.1

1114

13255

8306

FHL

Hysterectomy (related to abortion 8516, prolapse correction 8436)

0.5

10.0

1774

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

10.0

348

2383

R4190

NOMESCO Finland

Nutritional therapy

2.0

10.0

120

602

RS220

NOMESCO Finland

2.7

10.0

236

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

5.8

9.9

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

4.3

9.8

Y60.8

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during other surgical and medical care

6.3

9.8

JFC20

NOMESCO Finland

Other enterocolostomy

26.0

9.8

LEE00

NOMESCO Finland

Suture of vagina

5.9

9.8

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

2.6

9.8

274

R96

ICPC

Asthma

0.6

9.8

220

3312

A40.8

ICD-10 Finland

Other streptococcal sepsis

3.6

9.8

117

M01AB05

ATC

diclofenac; systemic, rectal

0.8

9.7

2744

29892

R83

ICPC

Respiratory infection other

0.7

9.7

504

6589

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

3.0

9.7

177

C51.13

ICD-10 Finland

Melanoma and labium minus

55.1

9.6

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

5.5

9.6

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

1.7

9.6

186

1096

N82.0

ICD-10 Finland

Vesicovaginal fistula

7.8

9.6

E66.9

ICD-10 Finland

Obesity, unspecified

1.9

9.5

139

751

JAA10

NOMESCO Finland

Excision of lesion of abdominal wall

7.1

9.5

18220

ICD-8 Finland

100.2

9.4

LCE20

NOMESCO Finland

Total exenteration of female pelvis

+∞

9.4

8010/3-C54.1

ICD-O-3

Carcinoma, NOS, of endometrium

+∞

9.4

8140/3-C57.9

ICD-O-3

Adenocarcinoma, NOS, of female genital tract, NOS

+∞

9.4

8000/3-C57.9

ICD-O-3

Neoplasm, malignant of female genital tract, NOS

+∞

9.4

8890/3-C55.9

ICD-O-3

Leiomyosarcoma, NOS, of uterus, NOS

+∞

9.4

C53.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of cervix uteri

+∞

9.4

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.1

9.4

108

531

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

0.8

9.3

1997

22321

J91

ICD-10 Finland

Pleural effusion in conditions classified elsewhere

8.7

9.3

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

13.7

9.2

N76.6

ICD-10 Finland

Ulceration of vulva

2.8

9.1

191

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.8

9.1

206

C10AA05

ATC

atorvastatin; oral

0.8

9.0

1378

15904

A41.9

ICD-10 Finland

Sepsis, unspecified

1.8

9.0

141

780

130

Kela drug reimbursment

Malignant tumour

1.5

9.0

297

2011

N87.2

ICD-10 Finland

Severe cervical dysplasia, not elsewhere classified

2.2

8.9

373

JFF13

NOMESCO Finland

Terminal enterostomy

7.4

8.9

R05

ICPC

Cough

0.8

8.9

725

8945

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

8.9

547

6992

C03CA01

ATC

furosemide; systemic

1.2

8.8

1486

12839

D48.49

ICD-10 Finland

Tumor of uncertain or unknown nature in the peritoneum, of unknown origin

14.0

8.7

R01AD08

ATC

fluticasone; nasal

0.8

8.6

905

10856

WX720

NOMESCO Finland

Own respiration

1.8

8.6

150

861

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

11.6

8.6

GAE06

NOMESCO Finland

Excision of lesion of chest wall

9.0

8.5

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.7

8.5

215

3165

K65.0

ICD-10 Finland

Acute peritonitis

2.8

8.5

188

J01FA10

ATC

azithromycin; systemic

0.8

8.5

2276

25034

AA1AD

NOMESCO Finland

CT of head and brain

0.8

8.5

786

9556

LCD97

NOMESCO Finland

Other laparoscopic hysterectomy

6.4

8.5

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

8.4

111

JFB50

NOMESCO Finland

Other resection of colon

5.4

8.4

C539, 8085, 3

ICD-O-3

90.2

8.4

KKA10

NOMESCO Finland

Biopsy of retroperitoneal tissue

90.2

8.4

LC002

NOMESCO Finland

Radical radiotherapy of uterus and uterine ligaments

90.2

8.4

J45.9

ICD-10 Finland

Asthma, unspecified

0.8

8.3

566

7146

1820C

ICD-9 Finland

Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[SARCOMA MYOMETRI]

+∞

8.3

8980/3-C54.2

ICD-O-3

Carcinosarcoma, NOS, of myometrium

+∞

8.3

18221

ICD-8 Finland

+∞

8.3

18011

ICD-8 Finland

+∞

8.3

J45.1

ICD-10 Finland

Nonallergic asthma

0.6

8.3

149

2352

N13.9

ICD-10 Finland

Obstructive and reflux uropathy, unspecified

4.6

8.3

LEF00

NOMESCO Finland

Anterior colporraphy with sutures for primary cystocele

0.6

8.2

124

2034

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.8

8.2

670

8270

LAE11

NOMESCO Finland

Unilateral laparoscopic oophorectomy

3.3

8.2

119

I89.8

ICD-10 Finland

Other specified noninfective disorders of lymphatic vessels and lymph nodes

14.5

8.2

8308

FHL

Hysterectomy and bilateral adnexal removal

1.7

8.2

157

925

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

3.0

8.2

147

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.8

8.2

715

8754

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

0.5

8.2

1544

R03BB04

ATC

tiotropium bromide; inhalant

0.7

8.1

182

2744

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

5.7

8.1

JAL23

NOMESCO Finland

Excision of local lesion of pelvic wall

33.4

8.1

KCD10

NOMESCO Finland

Partial cystectomy

11.7

8.1

LBE01

NOMESCO Finland

Laparoscopic salpingectomy

2.2

8.0

374

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

3.3

8.0

116

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

8.0

615

4841

N82.3

ICD-10 Finland

Fistula of vagina to large intestine

4.9

7.9

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.2

7.8

332

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.8

7.8

163

R87.7

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal histological findings

3.7

7.7

JA2CT

NOMESCO Finland

Abdominal puncture with CT guidance

45.0

7.7

D64.2

ICD-10 Finland

Secondary sideroblastic anaemia due to drugs and toxins

45.0

7.7

JGA60

NOMESCO Finland

Suture of rectum

15.0

7.7

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

4.2

7.7

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.4

7.6

269

KMAK

NOMESCO Finland

0.8

7.6

1816

20226

N71.1

ICD-10 Finland

Chronic inflammatory disease of uterus

4.7

7.6

R03BA05

ATC

fluticasone; inhalant

0.8

7.6

548

6869

C48.80

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum without histology

18.4

7.6

UJF32

NOMESCO Finland

Coloscopy

1.2

7.6

1250

10751

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.1

7.6

389

SPAT1076

SPAT

Cannulation of central vein

8.8

7.5

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

0.7

7.5

348

4632

M54.5

ICD-10 Finland

Low back pain

0.8

7.5

1158

13394

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.8

7.5

156

SPAT1088

SPAT

Blood transfusion

3.7

7.4

LFB20

NOMESCO Finland

Destruction of lesion of vulva or perineum

3.3

7.4

107

JAA11

NOMESCO Finland

Laparoscopic biopsy or excision of lesion of abdominal wall

80.2

7.4

AN1

Coronary angiography

0.7

7.4

254

3539

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

5.0

7.4

G56.0

ICD-10 Finland

Carpal tunnel syndrome

0.8

7.4

407

5282

G01AF05

ATC

econazole; vaginal

0.7

7.3

247

3454

R03BA02

ATC

budesonide; inhalant

0.8

7.3

538

6734

9100/3-C58.9

ICD-O-3

Choriocarcinoma, NOS, of placenta

+∞

7.3

8560/3-C53.9

ICD-O-3

Adenosquamous carcinoma of cervix uteri

+∞

7.3

1844A

ICD-9 Finland

Malignant neoplasm of other and unspecified female genital organs, Vulva, unspecified

+∞

7.3

C53.80

ICD-10 Finland

Overall malignant tumor of the cervix uteri without histology

+∞

7.3

8380/3-C53.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of cervix uteri

+∞

7.3

LCD11

NOMESCO Finland

Laparoscopically assisted vaginal hysterectomy

1.9

7.3

482

SAA01

NOMESCO Finland

Simple examination of mouth

0.9

7.3

2760

29695

R03AK07

ATC

formoterol and budesonide; inhalant

0.8

7.3

525

6582

Z30.5

ICD-10 Finland

Surveillance of (intrauterine) contraceptive device

0.5

7.2

1071

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

2.9

7.2

147

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

1.7

7.1

137

812

L01

ICPC

Neck symptom/complaint

0.8

7.1

406

5245

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

7.1

135

798

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.0

7.1

394

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

2.6

7.1

180

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

12.0

7.1

N93.8

ICD-10 Finland

Other specified abnormal uterine and vaginal bleeding

2.0

7.1

421

WX610

NOMESCO Finland

Patient controlled analgesia

3.5

7.1

W12

ICPC

Contraception intrauterine

0.5

7.1

1186

H02.3

ICD-10 Finland

Blepharochalasis

0.7

7.0

180

2644

H02

ICPC

Hearing complaint

0.7

7.0

356

4674

N93

ICD-10 Finland

Other abnormal uterine and vaginal bleeding

4.3

7.0

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

7.0

L08

ICPC

Shoulder symptom/complaint

0.8

7.0

614

7524

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

3.8

6.9

G03DA02

ATC

medroxyprogesterone; systemic (pregnen (4) derivatives)

1.3

6.9

663

5365

N99.3

ICD-10 Finland

Prolapse of vaginal vault after hysterectomy

0.5

6.9

878

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

5.8

6.9

JFB40

NOMESCO Finland

Resection of transverse colon

5.8

6.9

WX600

NOMESCO Finland

Single shot through catheter

2.4

6.9

231

JFC10

NOMESCO Finland

Ileotransversostomy

13.8

6.9

1CD01

NOMESCO Finland

4.6

6.9

Y60.0

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during surgical operation

3.5

6.9

D63.0

ICD-10 Finland

Anaemia in neoplastic disease

10.9

6.8

LWE00

NOMESCO Finland

Reoperation for deep haemorrhage in gynaecological surgery

3.2

6.8

104

JJB10

NOMESCO Finland

Atypcal resection of liver

6.1

6.8

LAC96

NOMESCO Finland

Other excision or destruction of lesion of ovary

40.1

6.8

L02BA01

ATC

tamoxifen; oral

1.5

6.7

249

1733

K03.64

ICD-10 Finland

Dental calculus supragingival

0.8

6.7

826

9779

8071/2-C51.9

ICD-O-3

Differentiated intraepithelial neoplasia of vulva, NOS

22.5

6.7

J01AA02

ATC

doxycycline; systemic

0.9

6.7

3629

38133

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

4.9

6.6

8305

FHL

Supravaginal amputation or resection

0.5

6.6

878

R03AK06

ATC

salmeterol and fluticasone; inhalant

0.8

6.6

369

4787

A11

ICPC

Chest pain NOS

0.7

6.6

183

2646

GD1AD

NOMESCO Finland

Thorax CT examination

1.6

6.6

160

1010

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

5.1

6.6

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

2.8

6.6

146

R01BA52

ATC

pseudoephedrine, combinations; oral

0.8

6.6

1200

13705

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.8

6.6

508

6318

N95

ICD-10 Finland

Menopausal and other perimenopausal disorders

0.4

6.6

703

LEB10

NOMESCO Finland

Excision of lesion of vagina

3.0

6.6

118

LWC00

NOMESCO Finland

Reoperation for deep infection in gynaecological surgery

8.7

6.5

F45.8

ICD-10 Finland

Other somatoform disorders

0.6

6.5

101

1647

A02BC05

ATC

esomeprazole; systemic

0.9

6.5

1670

18554

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

5.0

6.5

C10AX09

ATC

ezetimibe; oral

0.7

6.4

252

3439

LAG10

NOMESCO Finland

Oophoropexy

69.9

6.4

8477

FHL

Vulvectomy

69.9

6.4

KBH06

NOMESCO Finland

Ureteroureterostomy

69.9

6.4

JKA20

NOMESCO Finland

Cholecystectomy

1.8

6.4

105

592

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

2.5

6.4

192

LEE30

NOMESCO Finland

Closure of intestinovaginal fistula using graft or flap

14.3

6.4

H02AB06

ATC

prednisolone; systemic

0.9

6.4

1835

20229

M19.0

ICD-10 Finland

Primary arthrosis of other joints

0.7

6.4

268

3613

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

2.8

6.3

131

D06.9

ICD-10 Finland

Carcinoma in situ: Cervix, unspecified

6.5

6.3

I89.9

ICD-10 Finland

Noninfective disorder of lymphatic vessels and lymph nodes, unspecified

6.5

6.3

M01AE02

ATC

naproxen; oral, rectal

0.9

6.3

2267

24592

LEE10

NOMESCO Finland

Repair of vagina using graft or flap

18.0

6.3

R31

ICD-10 Finland

Unspecified haematuria

1.4

6.2

251

1777

8010/3-C53.9

ICD-O-3

Carcinoma, NOS, of cervix uteri

+∞

6.2

8020/3-C54.1

ICD-O-3

Carcinoma, undifferentiated, NOS, of endometrium

+∞

6.2

D39.12

ICD-10 Finland

Granulosa cell tumor of uncertain nature in the ovary

26.7

6.2

M01AG02

ATC

tolfenamic acid; oral, rectal

0.8

6.2

513

6331

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

0.7

6.2

234

3210

SAA03

NOMESCO Finland

Extended examination of mouth

0.8

6.2

1236

14020

Z01.1

ICD-10 Finland

Examination of ears and hearing

0.8

6.2

382

4884

SPAT1255

SPAT

Intravenous administration of medicine

1.4

6.2

257

1831

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

2.5

6.1

176

R07.3

ICD-10 Finland

Other chest pain

0.7

6.1

242

3296

M01AC06

ATC

meloxicam; systemic, rectal

0.9

6.1

1564

17406

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.9

6.1

1615

17929

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

2.6

6.1

160

ZLX00

NOMESCO Finland

Open surgery with vaginal approach

12.5

6.1

XF404

NOMESCO Finland

Ambulatory ECG

0.7

6.1

224

3083

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

0.8

6.0

471

5853

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.9

6.0

1364

15326

6170A

ICD-9 Finland

Endometriosis of uterus

0.4

6.0

512

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4281824)

1276

504

32.11

307.65

1.2

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1371

1390

12.58

307.65

1.6

1.4

360.2

131.5

pmol/l

13.29

1327

1353

(4035726)

1661

4740

4.50

307.65

1.5

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

293

42.20

307.65

2.7

1.1

4.9

2.0

ug/l

0.98

195

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2971

3530

16.09

307.65

10.9

2.0

119.6

53.8

u/ml

4.73

2919

3360

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3744

23530

2.65

269.11

5.2

3.9

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

185

21.93

249.27

5.4

2.7

137.7

46.3

ng/l

2.00

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

335

424

8.32

248.56

1.1

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

3586

23611

2.34

209.12

5.6

4.1

33.7

35.3

g/l

46.01

3409

21570

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1395

6047

2.72

207.42

2.5

3.8

5.9

22.0

ug/l

3.68

1028

4879

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1705

8241

2.51

201.78

5.4

2.7

0.8

mmol/l

23.11

1620

7534

(3044640) Blood type and Crossmatch panel - Blood

2739

16351

2.27

198.59

2.7

2.3

—

(3023368) Bacteria identified in Blood by Culture

2229

13398

2.07

146.51

4.7

4.0

—

(40768804) Tissue Pathology biopsy report

3140

21691

1.97

135.70

2.8

2.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2056

12393

2.02

130.63

2.7

2.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

758

2996

2.76

130.27

6.7

6.4

24.9

25.0

mmol/l

0.11

724

2790

(3003396) Base excess in Arterial blood by calculation

1142

5489

2.34

129.70

5.7

5.9

1.1

1.4

mmol/l

1.89

916

4379

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1136

5495

2.33

126.85

5.7

5.9

5.2

5.1

kpa

1.30

1089

5227

(3027801) Oxygen [Partial pressure] in Arterial blood

1133

5491

2.32

125.86

5.7

5.9

14.2

12.2

kpa

23.23

1086

5216

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3704

27474

1.95

125.15

8.4

5.6

9.6

10.7

umol/l

6.17

3554

25797

(3019060) Gas panel - Arterial blood

765

3146

2.65

121.11

4.2

4.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

3865

29396

1.93

117.24

16.7

8.6

3.8

4.0

e9/l

5.41

3467

25404

(3043409) Potassium [Moles/volume] in Arterial blood

464

1474

3.33

116.86

4.1

3.8

mmol/l

0.02

446

1392

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1766

10518

1.97

112.76

1.6

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

941

4459

2.32

108.82

5.9

6.5

116.0

118.2

g/l

3.33

911

4303

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

990

4890

2.23

103.24

1.9

2.0

0.2

g/l

0.73

940

4535

(3016502) Oxygen saturation in Arterial blood

973

4802

2.23

101.54

5.7

6.2

96.9

95.6

10.62

938

4615

(3003694) ABO and Rh group [Type] in Blood

1881

11887

1.86

97.48

1.4

—

(3032080) INR in Blood by Coagulation assay

2895

20836

1.77

96.82

8.1

8.7

1.2

inr

2.07

836

5734

(3020891) Body temperature

511

1973

2.74

90.58

4.6

4.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

148

261

5.79

80.06

4.5

1.2

18.4

4.3

ug/l

1.19

199

(3014007) Fractional oxyhemoglobin in Arterial blood

644

2954

2.33

78.82

6.2

7.0

94.7

93.9

3.15

644

2944

(3009261) Glucose [Presence] in Urine by Test strip

3369

26238

1.67

76.79

5.5

4.3

0.0

estimate

1.32

660

4628

(3021601) Nitrite [Presence] in Urine by Test strip

3335

25994

1.66

74.96

7.3

5.7

0.0

estimate

0.80

646

4548

(3026008) Bacteria identified in Urine by Culture

2752

20568

1.64

71.89

4.0

3.5

—

(3033658) Prothrombin time (PT) actual/Normal

1884

12800

1.70

71.16

4.4

3.6

94.9

92.5

4.25

1846

12449

(3020779) Urea [Moles/volume] in Serum or Plasma

751

3850

2.09

69.24

7.6

5.7

8.8

9.9

mmol/l

3.80

721

3619

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

453

1889

2.52

68.18

2.5

3.1

116.2

1234.9

u/ml

2.27

368

1589

(3014576) Chloride [Moles/volume] in Serum or Plasma

1045

6094

1.87

66.10

7.0

5.6

104.1

104.0

mmol/l

0.10

1023

5971

(3023487) Leukocytes [#/volume] in Peritoneal fluid

101

148

6.93

65.56

1.3

2.1

1319.0

4168.9

e6/l

0.39

(3031040) Bacteria [#/volume] in Urine by Automated count

4257

35912

1.68

65.16

6.3

5.3

1204.3

3128.7

e6/l

3.14

105

450

(40758558) Short blood count panel - Blood

1907

13283

1.65

63.91

12.4

6.4

—

(3042936) Bacteria identified in Isolate by Culture

1126

6799

1.81

63.37

2.0

1.9

—

(40768806) Pleura Pathology biopsy report

175

434

4.13

63.15

1.4

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3671

29972

1.61

62.74

5.0

4.2

6.8

6.7

mmol/l

4.10

3506

27902

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

129

7.23

62.16

1.3

1.9

4801.1

30985.0

e6/l

0.93

(3044007) Cell count panel - Peritoneal fluid

122

6.97

54.98

1.4

2.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

364

1553

2.43

51.87

2.6

2.9

0.4

u/ml

0.94

193

915

(3015377) Calcium [Moles/volume] in Serum or Plasma

2582

19983

1.52

51.72

4.5

3.2

2.4

mmol/l

2.54

2316

16934

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2069

15310

1.54

50.75

5.5

3.0

36.2

33.4

u/l

0.32

1978

14367

(3033799) Differential panel - Peritoneal fluid

130

6.46

50.61

1.3

1.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

779

4515

1.84

49.05

5.1

2.4

65.0

66.2

g/l

4.22

726

3967

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4584

40399

1.63

48.83

9.7

7.3

87.1

79.1

u/l

11.30

4362

37580

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

293

1194

2.53

46.02

1.8

2.3

3.8

3.6

g/l

1.13

280

1135

(3000991) Gas panel - Venous blood

691

3947

1.85

45.39

6.3

—

(40761535) Cells panel - Urine sediment

754

4495

1.78

42.86

4.4

3.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

706

4150

1.80

42.05

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3104

25677

1.45

40.46

5.6

5.3

1.2

mmol/l

52.31

2840

22843

(3014111) Lactate [Moles/volume] in Serum or Plasma

706

4253

1.75

38.46

5.5

5.2

1.2

1.3

mmol/l

1.29

687

4105

(3029937) Albumin [Presence] in Urine by Test strip

1841

13892

1.47

38.44

6.1

4.8

0.0

estimate

0.18

632

4563

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

844

5366

1.67

37.66

3.6

3.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

897

5800

1.65

37.46

1.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

159

526

3.08

37.11

1.3

1.4

1276.9

3799.9

e6/l

1.32

115

390

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3357

28437

1.42

36.75

6.3

6.0

1.2

mmol/l

57.29

2814

23683

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1098

7490

1.57

36.64

2.2

2.0

29.2

29.5

0.72

1072

7252

(3003434) Protein [Mass/volume] in Pleural fluid

169

586

2.94

36.32

1.3

1.5

37.9

31.7

g/l

7.58

155

528

(3028308) Erythrocytes [#/volume] in Pleural fluid

146

469

3.17

35.83

1.3

1.4

30128.1

60704.1

e6/l

0.82

274

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1030

6968

1.58

35.51

8.5

7.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

374

1893

2.04

34.87

2.0

1.9

3.7

1.7

ug/l

1.48

336

1629

(3039000) Anion gap in Blood

243

1042

2.39

34.15

5.0

6.6

10.9

11.0

mmol/l

0.08

220

938

(3018572) Chloride [Moles/volume] in Blood

243

1043

2.39

34.08

5.0

6.6

105.4

104.6

mmol/l

1.80

220

939

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

218

4.18

33.61

2.3

3.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4491

48586

0.67

32.88

4.2

4.6

4.8

mmol/l

0.03

3988

44017

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4633

49815

0.66

32.83

4.8

5.2

2.8

mmol/l

1.04

4087

44979

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

285

1332

2.20

32.70

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4446

48173

0.68

32.51

4.2

4.6

1.6

mmol/l

12.14

3925

43351

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2091

16577

1.41

31.88

3.4

2.4

55.7

58.0

u/l

1.16

1942

15022

(3002582) Erythrocytes [#/volume] in Urine

1957

15382

1.41

31.18

3.4

3.2

52.5

62.3

e6/l

0.41

1528

11444

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

244

1107

2.26

30.10

2.0

3.0

196.4

695.1

u/ml

1.11

221

986

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4282

46580

0.70

30.04

6.1

6.0

40.8

39.9

mmol/mol

6.47

3854

42308

(3035350) Ketones [Presence] in Urine by Test strip

3044

25858

1.37

29.76

5.8

4.3

0.0

estimate

0.50

659

4586

(3002256) Pathology report gross observation

968

6712

1.53

29.34

1.3

—

(40768795) Lymph node Pathology biopsy report

154

571

2.74

29.28

1.1

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1673

12911

1.41

29.17

5.4

4.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

190

785

2.47

28.99

3.0

1.9

426.3

3539.1

u/l

3.35

329

(3018095) Leukocytes [#/volume] in Urine

2259

18408

1.37

28.17

4.8

3.7

172.1

124.6

e6/l

0.98

1638

12463

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

427

2456

1.80

26.93

7.7

7.8

—

(3012441) Differential panel - Pleural fluid

125

435

2.91

26.77

1.4

1.5

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

5.74

26.73

12.2

4.4

35.6

50.9

u/l

0.97

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

258

1257

2.10

26.62

1.8

2.0

90.2

93.8

1.57

244

1159

(3026692) Albumin [Mass/volume] in Peritoneal fluid

5.34

26.31

1.1

1.4

20.1

12.4

g/l

7.79

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

248

1205

2.11

25.77

1.9

2.2

222.2

194.5

4.68

237

1135

(3036782) Glucose [Moles/volume] in Pleural fluid

109

361

3.06

25.49

1.2

1.3

5.4

6.7

mmol/l

5.48

103

334

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

807

5534

1.53

25.46

4.5

3.9

246.8

251.1

u/l

0.42

772

5162

(3045788) Cell count panel - Pleural fluid

118

412

2.90

25.14

1.3

1.5

—

(36304419) Bacteria [Presence] in Urine

1757

13975

1.37

24.67

3.3

3.1

—

(3000850) Epithelial cells [#/volume] in Urine

1406

10787

1.40

24.59

2.7

2.6

8.2

7.6

e6/l

0.54

1233

9320

(3025130) Human papilloma virus identified in Specimen

175

752

2.37

24.53

1.8

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

4029

36298

1.35

24.10

6.6

5.0

—

(3036489) Thrombin time

310

1671

1.90

24.03

1.7

1.8

21.6

21.1

0.58

283

1466

(3003458) Phosphate [Moles/volume] in Serum or Plasma

909

6479

1.48

23.66

4.7

4.4

1.0

mmol/l

0.19

829

5889

(3047181) Lactate [Moles/volume] in Blood

281

1482

1.94

23.26

5.0

5.7

1.3

mmol/l

0.00

250

1317

(3030467) Casts [#/volume] in Urine by Automated count

1784

14388

1.35

22.41

3.3

3.1

0.6

0.5

e6/l

0.71

1374

10646

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2318

19479

1.32

21.68

6.0

4.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1070

13991

0.71

21.42

1.6

1.5

1.3

mmol/l

5.88

859

11602

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4321

46376

0.74

21.37

3.8

4.1

1.3

mmol/l

12.36

3788

41242

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

352

2047

1.77

21.34

4.4

4.7

1.7

1.6

2.63

326

1930

(3026782) Osmolality of Urine

1302

10138

1.37

20.18

2.9

2.8

503.7

502.4

mosm/kgh2o

0.08

1121

8506

(3007930) Methemoglobin/Hemoglobin.total in Blood

345

2038

1.74

19.79

4.5

4.7

0.9

0.11

319

1922

(3021447) Carbon dioxide [Partial pressure] in Venous blood

660

4582

1.50

19.33

3.3

5.8

kpa

1.00

641

4457

(40761536) Microorganisms panel - Urine sediment

630

4342

1.51

19.11

6.8

4.6

—

(3002032) Base excess in Venous blood by calculation

655

4570

1.49

18.69

3.4

3.3

2.2

mmol/l

0.02

535

3794

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4519

47923

0.75

17.81

5.6

2.1

mu/l

0.07

4058

43507

(3019150) Specific gravity of Urine by Refractometry

1417

11392

1.32

17.32

5.6

5.0

1.0

kg/l

1.21

146

1846

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

454

2997

1.56

16.75

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

146

3.65

16.71

1.2

1.4

66.3

61.9

0.44

123

(3012544) pH of Venous blood

660

4724

1.45

16.43

3.3

7.4

—

(3035880) pH of Pleural fluid

231

2.97

15.37

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

124

564

2.22

15.36

3.0

1.9

7.1

2617.4

u/ml

0.90

119

549

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4656

48977

0.76

15.26

4.9

6.1

5.9

mmol/l

10.15

4127

43903

(3024354) Oxygen [Partial pressure] in Venous blood

545

3823

1.47

15.03

3.0

2.8

4.5

4.4

kpa

0.08

527

3702

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

571

4059

1.45

14.69

4.3

2.6

58.6

61.4

ml/min/173m2

1.30

262

1716

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

252

1486

1.73

14.59

2.5

3.7

44.3

39.8

u/ml

0.30

238

1437

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

764

5757

1.38

14.06

2.7

2.4

8.4

7.6

umol/l

0.41

647

4871

(3018418) pH of Serum or Plasma

2018

17351

1.25

13.78

3.5

3.8

7.4

0.29

380

3175

(40760892) CBC W Ordered Manual Differential panel - Blood

1274

10419

1.28

13.15

5.1

4.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2175

24685

0.81

12.90

2.2

2.3

78.8

81.2

nmol/l

3.63

1922

21724

(3021589) Normoblasts [#/volume] in Blood

2500

22131

1.23

12.69

12.6

9.6

0.0

e9/l

0.34

2051

17957

(3030981) Hyaline casts [#/volume] in Urine by Automated count

356

2368

1.54

12.69

2.8

2.6

0.2

0.3

e6/l

1.87

343

2297

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

880

6881

1.33

12.62

2.4

19.7

20.7

1.36

719

5756

(3027945) Reticulocytes/100 erythrocytes in Blood

746

5708

1.35

12.37

2.6

2.3

1.9

1.8

1.08

660

4971

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3938

42002

0.81

12.32

4.8

4.6

15.1

15.0

pmol/l

2.14

3551

37830

(40758358) Immune stain study

6.80

12.29

1.0

—

(3044889) 12 lead EKG panel

3860

35804

1.23

12.10

4.3

3.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1066

8602

1.29

12.10

1.8

—

(3017181) Myelocytes/100 leukocytes in Blood

586

4338

1.39

11.94

3.1

3.9

1.4

0.9

3.20

241

1172

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1012

8134

1.30

11.81

3.1

2.8

4.5

e6/l

0.01

542

4153

(3004789) Transferrin [Mass/volume] in Serum or Plasma

927

7385

1.30

11.55

2.3

2.2

2.4

g/l

10.50

849

6720

(3019198) Lymphocytes [#/volume] in Blood

2846

25696

1.21

11.36

6.1

5.7

1.7

1.9

e9/l

15.97

2460

22250

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1093

8970

1.27

10.71

3.0

2.7

1.6

1.8

e6/l

0.14

618

4943

(3027273) Bicarbonate [Moles/volume] in Venous blood

356

2456

1.48

10.68

3.1

3.0

25.4

25.5

mmol/l

0.18

348

2397

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

3.84

10.63

7.2

1.2

—

(3013115) Eosinophils [#/volume] in Blood

2867

26002

1.20

10.61

6.2

5.8

0.2

e9/l

12.06

2470

22447

(3049717) Cytology report of Urine Cyto stain

221

1374

1.63

10.56

2.4

2.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

276

2.44

10.54

1.3

1.4

10.1

12.8

u/l

2.50

262

(3006315) Basophils [#/volume] in Blood

2783

25185

1.20

10.51

6.0

5.6

0.0

e9/l

9.46

2367

21378

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5161

49731

1.32

10.46

20.7

15.0

33.2

22.1

mg/l

74.59

4545

39612

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

320

2170

1.50

10.45

1.5

1.3

—

(3001604) Monocytes [#/volume] in Blood

2768

25049

1.20

10.42

6.0

5.6

0.6

e9/l

1.81

2360

21273

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

719

9056

0.77

9.99

1.2

1.3

12.1

14.5

u/ml

0.38

274

3282

(3022948) Iron [Moles/volume] in Serum or Plasma

987

8069

1.27

9.92

2.3

11.5

12.1

umol/l

1.51

912

7335

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1358

11532

1.23

9.70

1.6

1.7

2.0

1.2

mg/l

6.85

1092

8833

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

210

2.59

9.61

1.8

1.7

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

10.02

9.54

1.5

1.2

119.6

215.4

umol/l

0.37

(3004119) Hemoglobin [Mass/volume] in Venous blood

415

3011

1.41

9.51

2.8

2.9

121.2

125.9

g/l

4.54

408

2940

(3026726) Creatinine [Moles/volume] in Specimen

6.54

9.34

1.1

3.2

1119.1

358.8

umol/l

0.32

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

745

5937

1.29

9.14

1.7

1.8

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

338

2387

1.44

9.01

2.6

2.5

1.2

0.75

338

2375

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

769

9481

0.78

8.93

1.3

55.0

36.5

iu/ml

1.13

246

3056

(3002030) Lymphocytes/100 leukocytes in Blood

2648

24076

1.18

8.90

6.0

25.1

27.9

27.22

2456

22079

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

331

2336

1.44

8.86

2.6

2.4

0.7

1.42

316

2238

(3019069) Monocytes/100 leukocytes in Blood

2598

23593

1.18

8.83

6.2

8.6

8.5

0.81

2427

21766

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

103

3.22

8.74

1.2

1.3

941.6

173.5

ug/l

0.37

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

388

2.08

8.61

1.5

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

104

3.19

8.61

1.4

18.1

23.4

0.57

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

159

962

1.67

8.52

1.2

1.4

—

(42870588) Differential panel, method unspecified - Blood

1960

17420

1.19

8.47

5.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

117

2017

0.57

8.33

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

740

5963

1.28

8.29

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

622

4905

1.30

8.25

2.2

2.3

33.0

37.7

u/l

1.40

531

4152

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2483

27111

0.85

7.91

2.5

2.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

515

1.88

7.79

1.6

1.2

24.9

20.4

u/l

1.42

410

(1617658) Protocol used for examination of sentinel lymph nodes

115

655

1.77

7.70

1.2

1.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

316

2273

1.41

7.65

3.6

3.5

24.4

24.5

mmol/l

0.32

275

2042

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

251

1733

1.47

7.58

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1319

11414

1.20

7.52

3.2

3.0

2.5

mmol/l

11.57

1179

9892

(3006504) Eosinophils/100 leukocytes in Blood

2562

23457

1.16

7.38

5.9

2.5

2.8

8.83

2382

21538

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

572

4531

1.29

7.32

2.4

4.0

5.6

ug/l

3.79

485

3748

(40757494) Bilirubin.total [Moles/volume] in Blood

265

2.20

7.32

1.7

2.5

15.1

17.3

umol/l

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

171

1099

1.57

7.24

4.1

2.8

1.4

1.6

mg/l

2.18

159

988

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2242

20361

1.16

7.09

3.8

30.9

82.8

ng/l

1.30

1683

14304

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

547

6843

0.78

7.05

4.2

4.7

32.4

34.1

2.96

334

4354

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

477

1.86

6.96

2.6

1.3

0.2

0.3

nmol/l

1.28

335

(3022096) Basophils/100 leukocytes in Blood

2487

22787

1.16

6.95

5.9

0.6

0.7

6.77

2314

20931

(3041096) Erythrocytes [Presence] in Urine by Automated

1496

13191

1.18

6.79

5.5

4.0

—

(3018010) Neutrophils/100 leukocytes in Blood

2583

23764

1.16

6.76

5.9

5.8

59.5

57.3

12.23

2402

21881

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

223

1546

1.46

6.64

2.2

2.9

—

(3000492) Spirometry study

314

4201

0.73

6.59

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

135

842

1.62

6.52

2.4

3.4

1.8

1.4

0.72

115

659

(3013707) Erythrocyte sedimentation rate by Westergren method

3709

38987

0.87

6.24

3.9

4.4

18.2

14.1

mm/h

32.65

3354

35696

(3008757) Leukocyte morphology finding [Identifier] in Blood

533

1.76

6.18

2.4

3.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

233

1653

1.43

6.16

1.4

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

220

3079

0.70

6.10

1.2

1.3

27.0

48.2

au/ml

—

137

(3023520) Reticulocytes [#/volume] in Blood

535

4302

1.27

6.08

2.7

2.4

71.8

70.6

e9/l

0.25

370

3213

(21494755) Public health laboratory ask at order entry panel

169

2477

0.67

6.03

1.3

—

(3022475) Manganese [Moles/volume] in Blood

4.52

5.98

1.3

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

516

4150

1.27

5.86

3.2

4.0

0.2

0.1

1.43

190

1094

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

250

3398

0.72

5.82

2.3

2.4

21.1

27.5

au/ml

—

157

(3022217) INR in Platelet poor plasma by Coagulation assay

840

7141

1.21

5.67

20.6

26.8

1.3

1.4

inr

0.86

957

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

235

1699

1.40

5.61

1.8

2.1

333.1

621.1

ug/l

1.16

226

1573

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

610

7291

0.82

5.18

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

163

1123

1.46

5.10

3.6

3.7

31.0

24.5

mg/l

1.17

119

681

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

206

1483

1.40

5.08

1.2

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1012

11540

0.85

5.07

1.2

1.3

1.0

1.6

u/ml

2.69

269

2890

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1506

13561

1.15

4.96

2.2

2.3

3.3

3.1

mg/l

1.51

1282

11497

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1479

0.63

4.78

1.5

1.7

5.5

3.4

mg/l

0.68

1074

(3002179) Metamyelocytes/100 leukocytes in Blood

485

3969

1.24

4.77

3.1

3.8

0.8

0.6

1.14

136

844

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

409

3288

1.26

4.70

1.6

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

214

2871

0.74

4.64

1.8

1.7

—

(3025159) Blasts/100 leukocytes in Blood

476

3908

1.24

4.55

3.2

4.0

0.0

0.4

1.69

156

925

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1813

16607

1.13

4.55

2.8

3.0

1667.9

1388.0

ng/l

1.15

1583

14251

(3019550) Sodium [Moles/volume] in Serum or Plasma

5291

51852

1.22

4.55

25.9

17.4

139.2

139.6

mmol/l

25.15

5195

50465

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2191

23546

0.89

4.48

2.1

94.5

98.5

pmol/l

3.37

1135

10797

(3009542) Hematocrit [Volume Fraction] of Blood

4198

43435

0.88

4.44

24.0

16.6

36.7

38.3

20.62

2666

28577

(1002224) Polysomnography panel

1399

0.64

4.37

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

589

6949

0.83

4.35

1.3

595.2

580.4

titre

0.06

124

1635

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3163

30006

1.12

4.27

3.9

3.0

54.4

45.9

u/l

4.37

2898

27261

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

102

2.46

4.20

1.0

1.2

—

(4010399)

314

3940

0.79

4.17

1.3

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

5294

51942

1.21

4.14

25.8

17.5

3.9

mmol/l

0.25

5195

50458

(3035637) Corticotropin [Mass/volume] in Plasma

582

1.57

4.11

1.6

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

136

1923

0.70

4.11

1.5

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

445

3674

1.23

4.06

4.5

3.1

4.4

pmol/l

0.18

406

3193

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

256

1984

1.30

3.98

1.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

477

0.42

3.96

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

216

1637

1.33

3.94

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

215

1630

1.33

3.92

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

212

1612

1.33

3.80

1.2

—

(1616796) Gas panel - Central venous blood

146

1047

1.40

3.78

3.2

3.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

852

9636

0.86

3.75

1.4

1.5

2.3

g/l

0.71

464

5313

(3019832) Treponema pallidum Ab [Presence] in Serum

154

2098

0.73

3.75

1.4

1.5

—

(3037121) Protein [Mass/volume] in Urine

229

1766

1.31

3.72

5.0

2.6

0.3

g/l

0.12

106

560

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

449

0.42

3.70

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

448

0.42

3.68

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

448

0.42

3.68

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

447

0.42

3.66

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

200

1523

1.32

3.57

5.1

5.0

—

(44790047)

472

1.58

3.44

1.5

1.4

—

(44806118)

472

1.58

3.44

1.5

1.4

—

(44790048)

472

1.58

3.44

1.5

1.4

—

(44790049)

472

1.58

3.44

1.5

1.4

—

(3010421) pH of Blood

175

1318

1.34

3.38

3.5

3.4

7.4

0.77

141

1096

(3043238) Trisomy 21 risk [Likelihood] in Fetus

387

0.41

3.33

1.4

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

315

3839

0.81

3.28

1.2

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

8.58

3.26

1.0

1.4

895.0

3651.4

umol/l

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.30

3.26

2.4

2.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

136

994

1.38

3.21

1.5

1.6

—

(3051651) Icteric interference index of Serum or Plasma

317

1.68

3.21

3.0

3.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

229

1.80

3.15

2.9

2.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.54

3.12

1.2

1.4

24.1

12.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

375

0.43

3.11

1.4

—

(1761868) Lipid panel - Serum or Plasma

1360

14770

0.90

3.09

3.2

3.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

536

0.52

3.09

1.5

1.4

—

(36660697) Celiac disease serology panel - Serum

349

4183

0.82

3.09

1.1

1.2

—

(3005033) Fetal Nuchal fold Thickness US

373

0.43

3.07

1.4

—

(3008898) HLA-B27 [Presence]

1369

0.70

3.00

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1204

0.68

2.99

1.2

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

564

1.48

2.95

4.6

5.2

7.6

7.2

mmol/l

0.40

462

(3002385) Erythrocyte distribution width [Ratio]

4142

40214

1.10

2.92

28.3

18.3

14.3

13.8

59.93

4072

39271

(4094501)

1257

0.70

2.92

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

267

2169

1.24

2.92

1.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

436

5085

0.85

2.87

1.6

1.7

—

(3021901) Oxygen saturation in Capillary blood

115

836

1.38

2.84

2.8

2.7

—

(3052851) Hemolysis interference index of Serum or Plasma

218

1737

1.26

2.83

3.1

3.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

136

1020

1.34

2.77

4.1

3.6

60.4

58.0

1.25

136

1020

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

110

802

1.38

2.69

1.3

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

237

2907

0.81

2.67

1.3

—

(3014891) Appearance of Pleural fluid

2.39

2.62

1.4

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

841

0.65

2.62

1.4

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

414

0.51

2.60

1.4

1.5

10.4

7.0

u/l

—

192

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1262

0.72

2.58

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.60

2.57

1.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

475

4127

1.16

2.55

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

154

1192

1.30

2.55

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

154

1192

1.30

2.55

1.2

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

555

4880

1.15

2.54

3.4

3.6

1.2

mmol/l

0.22

480

4152

(3011544) Albumin [Mass/volume] in Pleural fluid

3.03

2.52

1.2

21.1

17.9

g/l

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

314

3721

0.83

2.51

1.4

1.5

1.4

0.26

264

3185

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

626

1.41

2.51

1.3

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

163

1274

1.29

2.51

1.2

1.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

499

0.56

2.50

1.0

1.1

—

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

132

1007

1.32

2.44

2.2

2.4

124.2

68.4

ug/min

0.43

560

(40767503) Oxygen content in Capillary blood by calculation

140

1079

1.30

2.41

2.6

2.5

15.6

15.8

0.36

543

(3025941) Bacteria identified in Stool by Culture

337

2867

1.19

2.36

1.3

—

(3012501) Base excess in Blood by calculation

144

1119

1.29

2.34

3.5

2.8

mmol/l

0.01

808

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

568

1.41

2.33

1.4

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

150

1175

1.28

2.30

2.4

2.2

124.6

125.9

g/l

0.32

118

831

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

697

1.37

2.29

1.3

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

111

1458

0.76

2.25

1.3

21.3

5.1

u/ml

0.37

173

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.78

2.20

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

675

0.65

2.19

1.1

—

(40768797) Stomach Pathology biopsy report

704

7784

0.89

2.19

1.3

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

106

798

1.33

2.18

3.6

4.1

236.8

572.5

iu/ml

1.37

100

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

124

1592

0.77

2.13

1.2

1.3

23.9

39.1

u/ml

—

107

(3014051) Protein [Presence] in Urine by Test strip

106

1385

0.76

2.09

2.7

2.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

114

1475

0.77

2.09

1.3

18.4

6.4

u/ml

0.70

267

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

124

966

1.29

2.02

1.3

223.3

234.5

miu/ml

0.10

437

(40761511) CBC panel - Blood by Automated count

5163

50933

1.12

2.02

21.2

14.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

274

2327

1.19

2.00

1.4

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

180

2195

0.81

2.00

1.2

1.3

1.0

1.3

u/ml

0.16

205

(3003327) Ova and parasites identified in Stool by Light microscopy

131

1654

0.79

1.99

1.4

1.7

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.34

1.96

1.1

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1177

0.75

1.94

1.2

1.3

56.3

48.7

u/ml

0.18

145

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

701

1.33

1.94

1.2

1.3

—

(3010813) Leukocytes [#/volume] in Blood

5353

54068

0.88

1.93

35.4

22.4

6.6

e9/l

0.05

5215

52277

(3000963) Hemoglobin [Mass/volume] in Blood

5353

54067

0.88

1.92

35.6

22.5

124.8

130.7

g/l

179.41

5282

53146

(3026361) Erythrocytes [#/volume] in Blood

5352

54057

0.88

1.92

35.4

22.4

4.2

4.4

e12/l

110.41

5216

52268

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

397

1.44

1.90

1.3

—

(3035941) MCH [Entitic mass]

5352

54053

0.88

1.90

35.2

22.3

30.1

30.2

1.32

5274

53110

(3024731) MCV [Entitic volume]

5352

54052

0.88

1.89

35.2

22.3

91.5

91.3

2.57

5276

53110

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

275

1.53

1.89

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

275

1.53

1.89

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

144

1156

1.25

1.87

3.5

2.8

25.1

25.5

mmol/l

0.46

134

1021

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

129

1617

0.79

1.87

2.0

1.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1203

0.76

1.86

1.3

1.2

7.4

5.6

u/ml

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

260

1.54

1.86

1.4

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

649

0.68

1.85

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

320

2774

1.16

1.85

4.2

3.4

1.8

2.3

mmol/l

1.00

241

2141

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

328

0.55

1.82

2.7

1.8

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

428

0.61

1.81

1.3

—

504.9

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

183

1.64

1.81

1.9

1.4

35.4

31.4

umol/l

0.88

177

(3007461) Platelets [#/volume] in Blood

5352

54035

0.89

1.79

35.3

22.4

263.7

259.3

e9/l

4.42

5226

52445

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

136

0.37

1.74

2.6

1.3

189.6

87.6

ng/l

—

136

(3004451) EKG impression Narrative

257

1.52

1.73

1.3

—

(3019225) pH of Specimen

541

5984

0.89

1.72

4.3

4.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

252

2934

0.85

1.72

1.4

1.3

590.1

175.5

u/ml

0.52

229

2664

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

168

2027

0.82

1.72

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

230

0.48

1.71

1.2

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

118

1.78

1.69

1.7

1.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

141

1.71

1.67

2.3

1.7

4180.5

146957.8

u/ml

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

408

1.40

1.67

1.3

—

(3045414) Leukocytes [Presence] in Urine

222

2604

0.85

1.67

2.3

2.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

155

1877

0.82

1.66

2.0

2.3

0.5

0.8

g/l

1.11

128

1562

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.16

1.66

2.0

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1290

12156

1.08

1.63

1.6

1.7

31988981.2

27611558.1

pmol/l

0.10

1041

9699

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

185

2198

0.84

1.62

1.7

2.2

7.7

g/l

0.06

136

1602

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

111

1388

0.80

1.61

1.4

1.6

0.0

0.3

iu/ml

1.27

305

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

138

1124

1.23

1.61

1.4

1.5

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

128

1.72

1.60

1.9

1.7

28.8

27.7

0.15

117

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

185

2193

0.84

1.59

1.7

2.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

619

1.31

1.59

1.1

1.3

128.3

118.5

u/ml

0.61

128

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

185

2192

0.84

1.58

1.7

2.2

3.8

3.7

g/l

0.33

135

1519

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

466

1.36

1.54

1.3

1.2

—

(3009343) pH of Capillary blood

327

2884

1.14

1.53

4.2

3.4

7.4

0.08

401

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

614

1.31

1.53

1.3

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

632

1.30

1.52

2.1

2.0

31.6

32.3

0.74

625

(3036481) Cortisol [Moles/volume] in Serum or Plasma

532

4834

1.11

1.52

2.9

2.0

414.3

381.5

nmol/l

2.83

491

4354

(3000060) B lymphocytes [#/volume] in Blood

1.86

1.50

1.8

270.0

326.0

e6/l

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

469

1.35

1.49

2.4

2.8

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

174

2059

0.84

1.49

1.8

2.2

3.3

3.1

g/l

0.54

135

1554

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

132

1082

1.23

1.48

1.4

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

721

0.73

1.47

1.3

28.2

59.7

u/ml

—

(4034850)

199

1699

1.18

1.45

12.6

10.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

301

2652

1.14

1.45

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

146

1748

0.83

1.43

1.8

2.1

36.9

37.4

g/l

0.42

125

1440

(3016038) Potassium [Moles/volume] in Urine

430

1.35

1.42

1.3

1.1

33.6

34.0

mmol/l

0.04

342

(3019309) Folate [Moles/volume] in Red Blood Cells

1068

11341

0.93

1.42

1.8

1261.5

1192.4

nmol/l

1.40

793

8295

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

328

2920

1.13

1.36

4.2

3.4

5.2

kpa

0.28

307

2666

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

177

2069

0.85

1.34

1.7

2.2

9.6

10.1

g/l

0.60

143

1678

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

321

0.62

1.32

1.1

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

441

0.68

1.32

1.0

1.1

2.9

1.5

u/ml

—

100

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

228

2611

0.87

1.32

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1593

16638

0.94

1.28

2.2

2.1

151.1

174.9

u/l

1.11

1489

15403

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

532

4883

1.10

1.28

1.4

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.09

1.27

1.0

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

136

1615

0.84

1.25

1.8

2.2

0.0

g/l

0.90

121

1446

(44816559) Phosphatidylethanol [Mass/volume] in Blood

609

0.74

1.25

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

688

0.75

1.24

1.2

53.2

58.1

u/l

0.54

449

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.40

1.24

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

492

0.71

1.23

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

100

1.70

1.23

5.8

5.9

—

(4024509)

698

0.76

1.23

1.8

1.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

512

1.29

1.22

2.9

3.2

62.4

58.0

0.90

329

(3002523) Influenza virus A Ag [Presence] in Specimen

491

0.71

1.22

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

460

1.31

1.21

1.1

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

239

0.58

1.20

1.1

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

202

2312

0.87

1.19

1.1

125.0

192.9

titre

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.31

1.18

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

730

1.24

1.17

1.3

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

2.00

1.16

1.2

1.0

—

(40768441) Liver Pathology biopsy report

359

1.34

1.16

1.3

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

1.16

0.0

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

589

0.75

1.16

5.3

4.8

342.6

362.1

umol/l

0.46

496

(3014133) Dog dander IgE Ab [Units/volume] in Serum

392

0.69

1.15

1.0

13.0

3.4

u/ml

—

141

(3021788) Differential panel - Synovial fluid

987

0.81

1.12

1.5

—

(3000012) Reticulocyte production index

310

1.36

1.11

1.5

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

388

0.69

1.10

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

136

0.51

1.09

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

387

0.70

1.09

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

387

0.70

1.09

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

363

0.69

1.08

1.0

1.1

2.2

3.0

u/ml

0.34

133

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

386

0.70

1.07

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

386

0.70

1.07

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

315

0.67

1.07

1.0

0.3

0.1

u/ml

—

(3003181) Sodium [Moles/volume] in Urine

140

1198

1.17

1.07

1.3

58.3

60.7

mmol/l

0.35

108

944

(40759836) Histone Ab [Presence] in Serum by Immunoblot

385

0.70

1.06

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

580

0.76

1.06

1.2

1.4

—

23.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.92

1.06

1.0

1.3

131.6

116.3

ug/l

—

(3004616) Nuclear Ab [Presence] in Serum

692

0.78

1.06

1.4

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

545

0.75

1.05

4.5

4.6

62.9

103.8

u/ml

—

154

(44806420)

162

1.48

1.03

2.8

2.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

169

1472

1.15

1.03

1.5

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

454

4918

0.92

1.03

2.6

2.9

212.7

199.5

ng/l

0.25

413

4483

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1084

0.83

1.02

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

263

0.65

1.01

1.1

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

334

0.69

1.01

1.1

1.0

34.7

47.5

ng/l

1.78

228

(3023183) Ammonium ion [Moles/volume] in Plasma

781

1.21

1.01

1.6

2.5

31.2

32.4

umol/l

0.21

663

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

256

2296

1.12

1.01

1.8

1.6

1.7

1.6

g/l

1.12

203

1959

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

728

1.21

0.99

1.3

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

143

1235

1.16

0.99

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

482

0.75

0.98

3.4

3.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

447

0.74

0.97

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

331

0.69

0.97

1.1

1.0

761.1

712.2

ng/l

0.20

219

(3024522) Salmonella sp identified in Specimen by Organism specific culture

740

1.21

0.96

1.3

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

731

1.21

0.96

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

731

1.21

0.96

1.3

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

398

1.28

0.96

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

149

1.48

0.95

2.3

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

149

1.48

0.95

2.3

2.6

—

(3051611) Lipemic interference index of Serum or Plasma

641

1.22

0.95

2.9

3.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

119

0.50

0.93

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

328

0.70

0.93

1.1

1.0

271.9

361.3

ng/l

1.62

227

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

132

1523

0.86

0.92

1.8

2.2

0.0

g/l

0.50

117

1361

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

733

0.80

0.92

1.1

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

753

1.20

0.92

1.3

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

626

1.22

0.91

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

581

1.22

0.91

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

130

1499

0.86

0.90

1.8

2.3

0.0

g/l

0.00

117

1356

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

372

0.72

0.90

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

884

0.82

0.90

1.7

366.6

330.1

mu/l

0.37

780

(3035933) Granulocytes/100 leukocytes in Blood

101

0.49

0.89

1.2

1.6

—

(3017569) Oxygen content in Arterial blood

219

1.37

0.89

3.0

2.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

405

0.74

0.89

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

301

0.70

0.88

3.9

4.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

153

0.59

0.88

1.1

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

368

1.28

0.88

1.2

1.7

8.9

7.5

umol/l

0.31

260

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

395

1.27

0.87

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

404

1.26

0.87

1.4

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

404

1.26

0.87

1.4

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

404

1.26

0.87

1.4

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.86

0.87

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.00

0.87

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

369

1.28

0.86

1.1

—

(3004775) Volume in Urine collected for unspecified duration

334

1.29

0.86

2.2

2.3

586.8

639.7

0.49

233

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

356

0.73

0.85

1.0

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

1.67

0.85

1.8

2.5

14.4

14.3

ml/dl

0.04

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

167

0.60

0.84

2.1

2.5

—

31.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

502

0.78

0.84

1.1

1.0

0.7

1.1

u/ml

0.46

200

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

190

0.63

0.82

1.1

—

(3022621) pH of Urine by Test strip

353

3816

0.92

0.81

3.5

3.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.70

0.80

11.1

11.5

4.5

4.7

mmol/l

—

(3019977) pH of Arterial blood

267

1.31

0.80

3.5

2.7

7.4

0.06

(3027456) Digoxin [Moles/volume] in Serum or Plasma

164

1458

1.13

0.79

3.0

3.3

0.8

nmol/l

1.24

128

1142

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

200

0.65

0.79

1.8

2.1

277.4

131.2

umol/l

—

116

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

200

0.65

0.79

1.5

1.6

0.7

0.4

ug/l

—

125

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.82

0.79

1.5

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.79

0.0

1.1

—

(3037756) Immunofixation for Serum or Plasma

132

1158

1.14

0.79

1.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

321

1.28

0.79

1.8

1.9

14.7

14.0

0.12

115

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

300

3260

0.92

0.78

2.3

2.5

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.1

—

0.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

199

0.65

0.78

1.0

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

182

1.38

0.77

1.2

4.3

80.2

1307.2

mg/l

0.48

117

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.77

0.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

174

1.38

0.76

1.1

1.0

88.2

93.5

0.38

130

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.77

0.76

1.3

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

1.77

0.76

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.76

0.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

483

0.79

0.76

1.2

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

173

0.64

0.75

1.0

1.1

2602.5

1525.4

miu/ml

1.59

173

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.08

0.74

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.08

0.74

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

716

1.18

0.74

2.6

2.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

525

0.80

0.73

1.0

1.1

4.7

2.0

u/ml

0.55

241

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

132

0.61

0.73

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

132

0.61

0.73

1.0

1.1

—

(3024928) Oxygen saturation in Venous blood

111

969

1.15

0.72

2.4

2.6

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

435

0.78

0.72

6.2

3.3

13.0

13.3

1.06

429

(3017732) Neutrophils [#/volume] in Blood

330

3556

0.92

0.72

4.5

3.0

4.2

4.0

e9/l

0.63

240

2607

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

390

0.77

0.72

5.6

5.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

142

1.41

0.72

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

171

0.64

0.72

1.2

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

203

1.33

0.70

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

327

1.26

0.70

1.9

72.5

71.5

0.18

311

(3017817) Protein [Mass] in Urine collected for unspecified duration

381

1.24

0.70

2.5

2.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

142

0.63

0.69

1.4

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

468

4966

0.94

0.68

3.3

3.0

86.7

82.7

ng/l

0.50

384

4102

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

341

0.76

0.67

1.2

1.3

1.8

0.9

u/ml

0.21

160

(3041354) Potassium [Moles/volume] in Venous blood

723

1.16

0.67

2.6

2.2

4.0

mmol/l

0.36

718

(3035285) Chloride [Moles/volume] in Venous blood

723

1.16

0.67

2.6

2.2

104.7

105.5

mmol/l

0.63

718

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

121

0.58

0.67

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

517

0.81

0.66

1.1

1.2

377.6

344.4

nmol/l

0.41

428

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.79

0.66

1.2

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

123

1384

0.89

0.66

1.3

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

328

0.76

0.66

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

248

0.72

0.65

1.0

1.1

—

(3045716) Anion gap in Serum or Plasma

215

1.30

0.64

2.5

2.0

10.2

9.1

mmol/l

0.68

166

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

129

0.62

0.63

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

130

0.61

0.63

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

437

0.80

0.63

1.3

1.4

—

(3047189) Immunofixation for 24 hour Urine

223

0.72

0.62

2.7

1.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

190

1.32

0.62

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.55

0.62

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.63

0.62

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

656

1.16

0.61

1.4

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

434

0.81

0.60

1.0

1.1

—

5.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

323

0.77

0.60

2.2

2.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

139

1.37

0.60

1.0

1.1

99.0

93.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

163

0.67

0.59

1.1

—

(4062490)

477

0.82

0.59

1.2

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.54

0.59

2.0

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.59

0.0

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

714

0.85

0.58

1.3

1.5

0.5

0.6

g/l

0.74

511

(3008295) Osmolality of Serum or Plasma

617

0.84

0.58

1.3

1.4

276.3

274.0

mosm/kgh2o

0.31

454

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

421

0.81

0.58

1.0

1.1

—

94.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.56

0.58

4.9

8.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

309

1.23

0.58

2.0

1.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

343

0.79

0.58

1.0

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

596

1.16

0.56

1.1

135.1

122.6

1.65

523

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

119

1325

0.90

0.56

1.1

4.0

10.3

u/ml

1.44

122

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.46

0.56

5.3

8.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

330

0.79

0.56

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

586

6128

0.95

0.55

1.6

2.0

123.2

132.1

ug/g

0.25

447

4659

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

504

0.83

0.54

1.3

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

431

1.18

0.54

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

708

0.86

0.54

1.2

76.6

29.5

u/l

0.41

614

(4306422)

617

1.15

0.54

1.2

—

(40768446) Kidney Pathology biopsy report

126

0.63

0.54

1.6

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

552

1.16

0.54

1.4

47.8

37.5

u/l

1.39

446

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.54

0.53

1.5

2.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

204

0.73

0.52

1.2

1.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

143

1.33

0.52

1.0

1.1

90.0

89.9

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

241

1.25

0.52

1.0

1.1

ratio

—

(4015189)

146

0.68

0.52

1.6

2.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

161

1475

1.09

0.52

1.6

1.7

5.2

4.7

iu/l

0.23

492

(3012898) Urea [Moles/volume] in Urine

1.50

0.51

1.3

1.2

108.8

166.8

mmol/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

102

1138

0.89

0.51

1.7

1.8

—

(3022689) Creatine [Moles/volume] in Urine

135

0.67

0.51

1.7

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

789

0.87

0.51

2.2

1.7

1.0

0.8

nmol/l

1.38

657

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

270

0.78

0.51

2.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

267

2500

1.07

0.51

8.7

6.9

24.3

24.6

mmol/l

0.57

246

2325

(4027681)

206

1.26

0.50

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

596

0.85

0.50

1.1

0.4

1.0

u/ml

1.16

218

(3010144) Erythrocytes [#/volume] in Synovial fluid

500

1.16

0.50

1.4

16495.7

158650.3

e6/l

3.43

322

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

520

0.84

0.50

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.43

0.49

1.1

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

193

2080

0.93

0.48

1.7

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

212

0.75

0.48

1.4

1.5

14.3

15.9

pmol/l

0.90

172

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

190

1.26

0.47

2.7

2.5

35.0

42.7

1.01

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

634

1.14

0.47

1.1

1.2

259.9

289.4

u/ml

0.36

379

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

200

0.75

0.47

1.2

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

200

0.75

0.47

1.2

1.6

—

(4211845)

322

0.81

0.47

3.5

4.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

517

0.85

0.47

1.9

2.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

644

1.14

0.47

1.1

1.2

4.0

u/ml

0.01

186

(40768443) Skin Pathology biopsy report

238

2541

0.93

0.47

1.3

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.47

0.47

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

142

0.70

0.46

1.2

1.3

—

(3022145) Colonoscopy Study observation

605

5820

1.04

0.46

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

308

0.81

0.44

1.1

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.37

0.43

1.5

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

166

1.27

0.43

2.7

2.5

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

129

0.70

0.43

1.2

2.0

13.1

58.1

u/l

—

120

(3024869) Neuronal Ab [Presence] in Serum

1.41

0.43

1.1

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.66

0.42

1.0

—

(40765096) Chromosome analysis panel by Banding

122

1.31

0.42

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.56

0.42

1.2

1.0

—

(44813793)

349

0.83

0.42

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.40

0.42

2.3

2.0

—

(3011412) CD3 cells [#/volume] in Blood

406

1.16

0.42

1.9

2.2

1.1

e9/l

0.09

258

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

338

3552

0.95

0.42

1.2

115.5

146.2

iu/ml

1.00

136

1318

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

669

0.88

0.41

1.4

1.6

59.8

56.0

0.34

399

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

316

0.82

0.41

1.1

1.0

301.7

299.6

mg/l

0.05

269

(3000475) Leukocytes [#/volume] in Synovial fluid

121

1318

0.92

0.41

1.6

19604.6

12904.1

e6/l

0.64

941

(3045683) HLA typing for celiac disease panel - Blood or Tissue

249

1.21

0.41

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.41

0.0

1.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

2.3

—

3.5

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.40

0.0

1.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.5

—

586.2

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.40

0.0

1.5

—

309.0

—

(21494434) Karyotype in Bone marrow

398

1.16

0.40

1.2

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

249

0.80

0.40

1.5

1.7

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

2.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

502

1.14

0.40

2.8

2.4

3.6

2.5

u/field

0.43

188

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

454

0.86

0.39

1.2

18.3

43.7

u/ml

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

560

0.87

0.39

1.1

1.3

8.3

7.7

mmol/l

0.49

398

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

106

0.66

0.39

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

453

0.86

0.39

3.4

2.8

81.2

20.1

mg/l

0.75

310

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

324

0.83

0.39

1.3

13.4

11.6

mmol/l

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

192

2045

0.94

0.38

2.0

1.9

38.4

39.9

u/l

0.46

167

1784

(3011648) Oxygen content in Venous blood

363

1.16

0.38

1.4

1.9

9.1

10.5

1.48

363

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

345

0.84

0.38

1.6

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

136

0.73

0.37

1.0

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.32

0.37

1.4

1.7

53.1

56.5

pmol/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

123

1136

1.08

0.37

1.3

1.5

—

(3020650) Glucose [Presence] in Urine

116

1.29

0.37

1.1

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

397

0.86

0.37

1.3

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

134

1.27

0.36

1.2

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1030

10544

0.97

0.36

3.7

3.9

118.4

220.1

ng/l

2.26

830

8398

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.43

0.35

3.5

7.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

179

0.78

0.35

1.2

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

586

0.89

0.35

1.0

1.1

2.4

3.8

u/ml

0.73

217

(3009871) Measles virus Ab [Titer] in Serum

126

1.27

0.35

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

124

0.73

0.35

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

584

1.11

0.35

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

468

0.88

0.34

1.2

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4707

46829

1.03

0.34

22.1

14.1

75.6

75.5

ml/min/173m2

0.11

4119

38381

(3032057) Clostridioides difficile [Presence] in Stool

136

1.25

0.33

2.4

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

118

1.27

0.33

1.6

1.3

—

(3003338) MCHC [Mass/volume]

4038

40106

1.02

0.33

31.9

19.9

328.8

329.9

g/l

13.28

3988

39781

(3022313) Gas panel - Capillary blood

215

2038

1.06

0.33

4.6

3.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

836

1.09

0.32

1.3

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

174

1640

1.06

0.32

1.5

1.3

40.8

36.9

iu/l

0.66

144

1421

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

674

1.10

0.32

1.1

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

327

0.86

0.31

1.0

1.1

7.9

9.5

iu/ml

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.30

0.30

2.3

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

226

2371

0.95

0.30

1.7

1.8

—

(3000330) Specific gravity of Urine by Test strip

289

3012

0.96

0.29

5.3

3.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

278

1.15

0.29

1.3

1.5

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

130

0.77

0.29

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

130

0.77

0.29

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

130

0.77

0.29

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

130

0.77

0.29

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

420

1.12

0.29

1.8

2.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

756

1.09

0.28

1.2

1.3

—

nmol/l

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

641

1.09

0.28

1.1

1.2

2.4

4.2

u/ml

1.71

251

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

565

0.90

0.28

1.2

1.1

1.4

1437.5

iu/ml

—

120

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

280

0.86

0.28

1.3

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

938

0.93

0.27

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

205

1.17

0.27

1.3

1.2

131.9

133.7

nmol/l

0.10

205

(3025018) Bordetella pertussis Ab [Titer] in Serum

279

0.86

0.27

1.2

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

128

0.78

0.26

1.1

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

281

1.14

0.26

1.3

1.5

—

(3042631) Mycobacterium sp identified in Specimen

673

1.09

0.26

2.0

2.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

225

0.84

0.26

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2124

21475

0.98

0.26

2.7

2.8

176.4

109.2

ug/l

19.77

1950

19500

(3014271) Vancomycin [Susceptibility]

352

0.88

0.26

2.6

3.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

225

1.16

0.26

1.5

1.3

0.8

1.4

nmol/l

1.85

177

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.23

0.25

3.7

3.2

0.8

u/field

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.22

0.25

1.1

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1362

13421

1.02

0.25

1.5

21.1

21.7

nmol/l

0.57

1187

11156

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

213

0.84

0.25

1.1

—

28.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

767

0.92

0.24

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

127

1200

1.06

0.24

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

0.72

0.24

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

312

1.12

0.24

1.3

1.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

124

1.21

0.24

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

115

1.22

0.23

1.1

1.4

—

(3013512) EKG study

1630

16101

1.02

0.23

4.3

4.1

—

(3044290) Cell count panel - Cerebral spinal fluid

919

0.93

0.23

1.2

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

379

3903

0.97

0.23

1.8

2.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

474

0.91

0.23

1.2

1.5

0.5

0.4

g/l

0.74

320

(3028192) IgG subclass 2 [Mass/volume] in Serum

474

0.91

0.23

1.2

1.5

2.7

2.6

g/l

0.09

316

(3041806) Other cells [#/volume] in Blood by Manual count

1.28

0.23

1.0

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

189

1813

1.04

0.22

4.8

3.7

24.7

25.3

mmol/l

1.45

171

1619

(3000570) Elastase.pancreatic [Mass/mass] in Stool

169

1765

0.96

0.21

1.4

259.4

280.2

ug/g

0.68

1014

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

210

1.14

0.21

3.3

4.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

210

1.14

0.21

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

124

0.81

0.21

1.3

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.19

0.21

1.0

2.8

—

27.0

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

4.8

—

1.6

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.3

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.21

0.0

1.0

—

3.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

10.5

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

167.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.22

0.21

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

262

0.88

0.21

1.1

—

(3010503) CD19 cells [#/volume] in Blood

283

0.88

0.21

1.8

2.4

0.1

0.7

e9/l

1.53

272

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

104

0.77

0.21

1.0

—

(40757373) Influenza virus identified in Isolate

105

0.76

0.21

1.6

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

272

0.88

0.20

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.20

0.0

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

0.78

0.20

1.0

1.1

—

(3016750) Collection duration of Urine

250

1.12

0.19

2.0

2.2

510.7

504.0

min

0.18

190

(3006922) Hepatitis E virus Ab [Presence] in Serum

281

0.89

0.19

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.18

0.19

1.2

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.15

0.19

1.0

1.8

—

(3023419) Bacteria identified in Sputum by Culture

612

0.93

0.18

2.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

299

1.10

0.18

2.1

2.2

2.4

2.5

u/field

0.01

203

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

259

0.89

0.18

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.21

0.18

1.0

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

107

1123

0.95

0.18

1.2

1.3

569.4

554.0

mg/l

0.06

102

1067

(3020491) Glucose [Moles/volume] in Blood

348

1.09

0.17

1.7

2.1

7.3

7.0

mmol/l

0.51

233

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

174

0.86

0.17

1.0

1.1

28.7

382.4

ng/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.21

0.17

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

310

1.10

0.17

1.2

1.4

—

(3027944) Amphetamines [Presence] in Urine

620

1.07

0.17

1.4

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

475

0.93

0.17

1.2

1.5

6.6

6.7

g/l

0.04

318

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

947

0.95

0.17

1.3

—

89.6

—

(3044941) Cell count panel - Synovial fluid

824

0.95

0.17

1.5

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

371

0.92

0.16

1.8

2.5

—

(3045142) Bone marrow Pathology biopsy report

536

0.93

0.16

1.1

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

966

0.95

0.16

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

139

1.15

0.16

1.1

1.4

36.1

34.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

156

1506

1.04

0.15

1.5

1.7

0.2

g/l

1.12

148

1409

(3007916) DNA double strand Ab [Titer] in Serum

1.15

0.15

1.1

1.2

—

95.3

—

(3000494) Fungus identified in Specimen by Culture

579

5886

0.98

0.15

1.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

245

1.10

0.15

1.5

1.6

2.2

4.5

nmol/l

1.19

201

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

140

0.86

0.15

2.7

1.7

8.1

9.0

ug/l

0.84

140

(3042111) Morphology [Interpretation] in Bone marrow Narrative

820

1.05

0.15

1.4

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

296

0.91

0.14

1.0

1.1

54.2

4.4

nmol/l

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

169

1.12

0.14

1.1

1.3

—

(4198724)

0.80

0.14

1.1

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

275

0.91

0.14

15.5

11.9

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

118

0.85

0.14

1.5

3.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

141

1.14

0.13

1.4

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

222

0.90

0.13

1.0

1.1

u/l

—

107

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

113

1.15

0.13

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

1557

15453

1.01

0.12

3.1

3.0

6.2

6.1

mmol/l

0.13

1281

12686

(4268621)

433

1.06

0.12

2.3

2.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

126

1302

0.97

0.12

1.8

2.0

10.6

11.5

mg/l

0.71

115

1188

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

531

1.06

0.12

1.3

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

806

1.04

0.12

1.2

—

(3017704) Immunofixation for Urine

268

1.08

0.12

1.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

241

0.91

0.12

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

251

0.92

0.12

1.2

1.6

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

147

0.88

0.11

11.7

10.6

881.1

843.4

nmol/l

0.14

140

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

159

1548

1.03

0.11

1.5

1.6

1.2

g/l

1.02

153

1451

(3000764) Benzodiazepines [Presence] in Urine

631

1.05

0.11

1.4

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

153

1.11

0.11

1.1

—

(3028433) Virus identified in Specimen by Culture

182

1.10

0.11

1.1

—

(3015183) Erythrocyte sedimentation rate

157

0.89

0.11

1.2

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

250

0.92

0.11

1.2

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

250

0.92

0.11

1.2

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

250

0.92

0.11

1.2

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

984

0.96

0.11

1.2

1.3

3.8

3.7

mmol/l

0.12

928

(3026493) Urate [Moles/volume] in Serum or Plasma

1249

12397

1.01

0.10

2.6

2.4

5079.2

5562.0

umol/l

0.13

1052

10352

(40768793) Breast Pathology biopsy report

192

1964

0.98

0.10

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.15

0.10

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.09

0.09

1.0

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

654

1.04

0.09

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

242

1.07

0.09

1.4

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

242

1.07

0.09

1.4

1.6

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

1.04

0.09

7.4

6.9

0.2

0.4

umol/l

—

(3028300) Cannabinoids [Presence] in Urine

635

1.04

0.09

1.4

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

155

1.10

0.09

1.6

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

644

0.96

0.08

1.2

1.3

—

33.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

532

0.96

0.08

1.1

1.6

1.5

g/l

0.64

459

(40760888) Immunoglobulin light chains.free panel - Serum

131

1341

0.98

0.08

2.8

3.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

977

0.97

0.08

1.3

1.4

449.7

1442.9

e6/l

1.84

797

(4146454)

578

1.04

0.08

2.8

2.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

205

2086

0.98

0.08

1.4

1.6

37.5

15.1

u/ml

—

(3012516) Albumin [Mass/volume] in Urine

1507

14995

1.01

0.07

3.2

3.1

491.8

468.0

mg/l

0.06

920

8339

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.86

0.07

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.83

0.07

1.3

1.5

—

(3042733) HLA Ab [Presence] in Serum

0.80

0.07

1.5

4.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.05

0.07

2.4

2.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

975

0.97

0.07

1.2

1.4

12.8

37.6

e6/l

0.93

751

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

461

1.04

0.07

1.4

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.84

0.07

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

772

0.97

0.07

2.2

2.1

30.7

26.7

mg/l

0.22

202

(3016228) CD19 cells/100 cells in Blood

204

0.93

0.07

1.8

2.0

7.1

9.1

0.70

199

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.05

0.07

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

114

1115

1.02

0.07

2.2

2.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

353

3569

0.99

0.06

2.6

2.9

10.2

g/l

0.01

321

3235

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

680

1.03

0.06

1.0

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

779

1.03

0.06

1.6

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

720

0.97

0.06

1.6

—

(3027008) Opiates [Presence] in Urine

631

1.03

0.06

1.4

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

203

0.94

0.06

2.1

2.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

532

5279

1.01

0.06

1.4

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

496

0.97

0.05

1.3

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

192

0.94

0.05

1.1

0.8

0.5

u/ml

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

141

0.92

0.05

1.3

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

110

0.91

0.05

1.2

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

323

0.96

0.05

1.2

1.1

81.7

79.0

u/l

0.13

249

(3014599) Egg white IgE Ab [Units/volume] in Serum

179

1.06

0.05

1.1

1.0

0.8

0.6

u/ml

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

179

1.06

0.05

1.2

1.3

4.5

3.6

umol/l

0.61

165

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

357

1.04

0.04

1.6

1.5

—

(3011436) Histone Ab [Units/volume] in Serum

130

0.92

0.04

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

140

1.07

0.04

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1007

0.98

0.04

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

322

0.96

0.04

1.2

1.1

19.0

24.2

u/l

0.37

241

(3034860) Kappa light chains.free [Mass/volume] in Serum

182

1800

1.01

0.04

2.5

3.2

35.1

79.6

mg/l

0.79

147

1451

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

170

0.94

0.04

1.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

109

0.92

0.04

1.2

1.1

0.3

1.4

u/ml

—

(3036670) Protein [Mass/volume] in Synovial fluid

190

0.95

0.04

1.2

35.9

38.6

g/l

0.30

(3028026) IgM [Mass/volume] in Serum or Plasma

283

2809

1.01

0.03

1.7

1.8

1.2

1.4

g/l

0.62

250

2514

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

250

0.96

0.03

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

199

0.95

0.03

1.7

1.9

—

(3016879) Cocaine [Presence] in Urine

579

1.02

0.02

1.4

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

249

0.96

0.02

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

129

1277

1.01

0.02

1.1

1.2

71.1

157.6

titre

—

102

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

411

1.02

0.02

1.2

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

242

1.03

0.02

1.2

—

(3012565) Volume of 24 hour Urine

248

0.97

0.02

2.0

1952.1

1807.9

0.31

220

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.08

0.02

2.5

1.4

—

(3011985) Renin [Units/volume] in Plasma

739

0.99

0.01

1.2

1.4

40.6

46.9

mu/l

0.31

652

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

181

1800

1.01

0.01

2.5

3.2

44.8

44.4

mg/l

0.01

146

1448

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

688

0.99

0.01

1.1

1.3

286.1

331.2

pmol/l

0.31

526

(3020682) Albumin/Creatinine [Ratio] in Urine

1577

15781

1.00

0.01

4.0

3.7

12.4

8.2

mg/mmol

2.52

959

8797

(3045424) Erythrocytes [Presence] in Urine

943

1.01

0.01

1.6

—

(3034426) Prothrombin time (PT)

144

1.04

0.00

1.1

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

446

0.99

0.00

1.2

1.3

—

(3044927) Protein electrophoresis panel - Urine

584

1.01

0.00

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5244

52446

1.00

0.00

15.8

10.9

23.3

23.1

u/l

0.39

5079

50199

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

252

0.99

0.00

1.7

2.5

586.0

727.0

e6/l

—

110

(3048879) Bone marrow aspiration report

145

1.03

0.00

1.1

1.7

—

(3024263) Appearance of Synovial fluid

255

0.98

0.00

1.4

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

134

0.97

0.00

1.5

1.6

—

(3036603) Volume of Urine

356

1.01

0.00

1.3

1.5

1571.0

1941.6

0.69

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

497

1.01

0.00

1.4

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

174

1744

1.00

0.00

2.6

3.1

1.3

1.6

ratio

0.46

128

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

469

1.00

0.00

1.4

1.5

35.7

0.00

267

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

119.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(44806071)

0.94

0.00

1.0

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

2.4

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.01

0.00

1.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

2.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

2.4

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.00

0.00

1.0

1.5

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.86

0.00

1.0

2.0

18.1

19.2

umol/l

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.8

—

12.8

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

320

1.00

0.00

2.0

1.7

—

(3024932) HLA-DR beta [Type]

0.95

0.00

1.1

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.01

0.00

1.4

1.3

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.86

0.00

1.0

1.1

—

(3013762) Body weight Measured

0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1290.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.00

0.00

1.0

—

(4133840)

0.99

0.00

1.1

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

3.2

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.01

0.00

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

5.1

—

1.7

—

(3024471) HLA-A [Type]

1.01

0.00

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.97

0.00

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.00

0.00

1.1

1.5

—

(3002619) Bacteria identified in Specimen by Culture

110

1.00

0.00

1.1

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(4212803)

0.89

0.00

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_FEMALE_GENITAL – malignant neoplasm of female genital organs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

malignant neoplasm of female genital organs

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints